CA3132191A1

CA3132191A1 - Compositions et methodes de prevention et/ou de traitement de la covid-19

Compositions et methodes de prevention et/ou de traitement de la covid-19

Info

Publication number: CA3132191A1
Authority: CA; Canada
Prior art keywords: nucleic acid; mol; oxy; acid vaccine; ethyl
Prior art date: 2021-09-28
Legal status : Pending

Application number

CA3132191A

Other languages

English (en)

Inventor

Eric G. Marcusson

Jumai Adeola Abioye

Natalia Martin Orozco

Yuko Arita

Current Assignee

Providence Therapeutics Holdings Inc

Original Assignee

Providence Therapeutics Holdings Inc

Priority date

2021-09-28

Filing date

2021-09-28

Publication date

2023-03-28

2021-09-28 Application filed by Providence Therapeutics Holdings Inc filed Critical Providence Therapeutics Holdings Inc

2021-09-28 Priority to CA3132191A priority Critical patent/CA3132191A1/fr

2022-01-21 Priority to CA3146392A priority patent/CA3146392A1/fr

2022-09-23 Priority to TW111136145A priority patent/TW202330923A/zh

2022-09-28 Priority to ARP220102605A priority patent/AR127169A1/es

2022-09-28 Priority to PCT/CA2022/051442 priority patent/WO2023050003A1/fr

2023-03-28 Publication of CA3132191A1 publication Critical patent/CA3132191A1/fr

Status Pending legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 118
238000000034 method Methods 0.000 title claims abstract description 76
208000025721 COVID-19 Diseases 0.000 title claims abstract description 40
238000011282 treatment Methods 0.000 title abstract description 16
230000002265 prevention Effects 0.000 title abstract description 14
108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 claims abstract description 353
229940023146 nucleic acid vaccine Drugs 0.000 claims abstract description 353
102000040430 polynucleotide Human genes 0.000 claims abstract description 232
108091033319 polynucleotide Proteins 0.000 claims abstract description 232
239000002157 polynucleotide Substances 0.000 claims abstract description 232
241001678559 COVID-19 virus Species 0.000 claims abstract description 180
101710172711 Structural protein Proteins 0.000 claims abstract description 38
230000000116 mitigating effect Effects 0.000 claims abstract description 3
-1 uracil nucleoside Chemical class 0.000 claims description 451
150000002632 lipids Chemical class 0.000 claims description 128
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 86
108090000623 proteins and genes Proteins 0.000 claims description 84
108020004414 DNA Proteins 0.000 claims description 79
108020004999 messenger RNA Proteins 0.000 claims description 77
150000007523 nucleic acids Chemical group 0.000 claims description 76
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 75
102000004169 proteins and genes Human genes 0.000 claims description 74
229930182558 Sterol Natural products 0.000 claims description 72
235000003702 sterols Nutrition 0.000 claims description 72
150000003432 sterols Chemical class 0.000 claims description 71
229940096437 Protein S Drugs 0.000 claims description 53
108091028043 Nucleic acid sequence Proteins 0.000 claims description 49
239000008194 pharmaceutical composition Substances 0.000 claims description 46
101710198474 Spike protein Proteins 0.000 claims description 44
108020005345 3' Untranslated Regions Proteins 0.000 claims description 43
235000012000 cholesterol Nutrition 0.000 claims description 43
150000003904 phospholipids Chemical class 0.000 claims description 33
108020003589 5' Untranslated Regions Proteins 0.000 claims description 29
108020004705 Codon Proteins 0.000 claims description 28
239000002105 nanoparticle Substances 0.000 claims description 27
239000002777 nucleoside Substances 0.000 claims description 24
NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims description 18
230000028993 immune response Effects 0.000 claims description 15
STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 14
239000000546 pharmaceutical excipient Substances 0.000 claims description 13
230000001965 increasing effect Effects 0.000 claims description 12
230000003472 neutralizing effect Effects 0.000 claims description 11
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Natural products O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 10
238000007918 intramuscular administration Methods 0.000 claims description 10
208000024891 symptom Diseases 0.000 claims description 10
230000000694 effects Effects 0.000 claims description 9
210000001744 T-lymphocyte Anatomy 0.000 claims description 8
229940035893 uracil Drugs 0.000 claims description 7
101000629318 Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein Proteins 0.000 claims description 6
230000006698 induction Effects 0.000 claims description 4
239000007924 injection Substances 0.000 claims description 4
238000002347 injection Methods 0.000 claims description 4
210000002966 serum Anatomy 0.000 claims description 4
108090000978 Interleukin-4 Proteins 0.000 claims description 3
230000005867 T cell response Effects 0.000 claims description 3
230000001939 inductive effect Effects 0.000 claims description 3
102100037850 Interferon gamma Human genes 0.000 claims description 2
108010074328 Interferon-gamma Proteins 0.000 claims description 2
108010002350 Interleukin-2 Proteins 0.000 claims description 2
210000003719 b-lymphocyte Anatomy 0.000 claims description 2
230000036755 cellular response Effects 0.000 claims description 2
239000011521 glass Substances 0.000 claims description 2
231100000673 dose–response relationship Toxicity 0.000 claims 3
230000016784 immunoglobulin production Effects 0.000 claims 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
238000004519 manufacturing process Methods 0.000 abstract description 4
238000002360 preparation method Methods 0.000 abstract description 2
230000001225 therapeutic effect Effects 0.000 abstract description 2
108090000765 processed proteins & peptides Proteins 0.000 description 177
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 155
102000004196 processed proteins & peptides Human genes 0.000 description 152
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 131
229920001184 polypeptide Polymers 0.000 description 124
239000012634 fragment Substances 0.000 description 109
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 78
230000004048 modification Effects 0.000 description 74
238000012986 modification Methods 0.000 description 74
235000018102 proteins Nutrition 0.000 description 71
125000003729 nucleotide group Chemical group 0.000 description 69
125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 65
239000002773 nucleotide Substances 0.000 description 65
238000006467 substitution reaction Methods 0.000 description 65
FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 64
WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 64
235000001014 amino acid Nutrition 0.000 description 57
150000001413 amino acids Chemical class 0.000 description 57
229940024606 amino acid Drugs 0.000 description 56
238000009472 formulation Methods 0.000 description 49
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 40
230000000670 limiting effect Effects 0.000 description 40
239000002502 liposome Substances 0.000 description 39
102000039446 nucleic acids Human genes 0.000 description 35
108020004707 nucleic acids Proteins 0.000 description 35
150000001412 amines Chemical class 0.000 description 33
101710085938 Matrix protein Proteins 0.000 description 31
101710127721 Membrane protein Proteins 0.000 description 31
101710141454 Nucleoprotein Proteins 0.000 description 31
229920001223 polyethylene glycol Polymers 0.000 description 31
108091081024 Start codon Proteins 0.000 description 29
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 28
102100031673 Corneodesmosin Human genes 0.000 description 27
101710139375 Corneodesmosin Proteins 0.000 description 27
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 27
235000000346 sugar Nutrition 0.000 description 26
SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 25
125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 25
OYHQOLUKZRVURQ-UHFFFAOYSA-M octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC([O-])=O OYHQOLUKZRVURQ-UHFFFAOYSA-M 0.000 description 23
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 22
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 22
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 22
230000035772 mutation Effects 0.000 description 21
108091026890 Coding region Proteins 0.000 description 20
239000002245 particle Substances 0.000 description 20
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 19
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 18
125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 18
101710204837 Envelope small membrane protein Proteins 0.000 description 17
101710145006 Lysis protein Proteins 0.000 description 17
108010076504 Protein Sorting Signals Proteins 0.000 description 17
108091023045 Untranslated Region Proteins 0.000 description 17
230000027455 binding Effects 0.000 description 17
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 17
238000003786 synthesis reaction Methods 0.000 description 17
GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 16
229960005486 vaccine Drugs 0.000 description 16
125000000539 amino acid group Chemical group 0.000 description 15
230000015572 biosynthetic process Effects 0.000 description 15
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 15
230000014616 translation Effects 0.000 description 15
238000012384 transportation and delivery Methods 0.000 description 15
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 14
125000003275 alpha amino acid group Chemical group 0.000 description 14
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 14
210000004027 cell Anatomy 0.000 description 14
102220599672 Spindlin-1_D614G_mutation Human genes 0.000 description 13
230000006870 function Effects 0.000 description 13
238000013519 translation Methods 0.000 description 13
WDSCDQQQRGGVPJ-AQABUGPSSA-N (e,2r,3r,8z)-8-[(8s,8as)-8-hydroxy-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-6-ylidene]-4,7-dimethyloct-4-ene-2,3-diol Chemical compound C[C@]1(O)CC(=C/C(C\C=C(/C)[C@@H](O)[C@@H](C)O)C)/CN2CCC[C@H]21 WDSCDQQQRGGVPJ-AQABUGPSSA-N 0.000 description 12
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 12
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 12
229940029575 guanosine Drugs 0.000 description 12
MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 12
108700021021 mRNA Vaccine Proteins 0.000 description 12
229940126582 mRNA vaccine Drugs 0.000 description 12
229920000642 polymer Polymers 0.000 description 12
238000000746 purification Methods 0.000 description 12
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 12
DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 11
125000003835 nucleoside group Chemical group 0.000 description 11
102000005962 receptors Human genes 0.000 description 11
108020003175 receptors Proteins 0.000 description 11
239000000126 substance Substances 0.000 description 11
108091007433 antigens Proteins 0.000 description 10
102000036639 antigens Human genes 0.000 description 10
QPMJENKZJUFOON-PLNGDYQASA-N ethyl (z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate Chemical compound CCOC(=O)C(\C#N)=C(/Cl)C(F)(F)F QPMJENKZJUFOON-PLNGDYQASA-N 0.000 description 10
208000015181 infectious disease Diseases 0.000 description 10
150000003833 nucleoside derivatives Chemical class 0.000 description 10
230000002829 reductive effect Effects 0.000 description 10
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 9
201000010099 disease Diseases 0.000 description 9
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
238000004128 high performance liquid chromatography Methods 0.000 description 9
238000001727 in vivo Methods 0.000 description 9
238000006386 neutralization reaction Methods 0.000 description 9
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
AJAMRCUNWLZBDF-UHFFFAOYSA-N propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCCC AJAMRCUNWLZBDF-UHFFFAOYSA-N 0.000 description 9
102200128238 rs201124247 Human genes 0.000 description 9
XBBMJUWOCGWHRP-UHFFFAOYSA-N 3-octanoyloxypropyl octanoate Chemical compound CCCCCCCC(=O)OCCCOC(=O)CCCCCCC XBBMJUWOCGWHRP-UHFFFAOYSA-N 0.000 description 8
241000282414 Homo sapiens Species 0.000 description 8
229910019142 PO4 Inorganic materials 0.000 description 8
238000003556 assay Methods 0.000 description 8
239000003795 chemical substances by application Substances 0.000 description 8
238000012217 deletion Methods 0.000 description 8
230000037430 deletion Effects 0.000 description 8
230000007935 neutral effect Effects 0.000 description 8
238000002255 vaccination Methods 0.000 description 8
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical class NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 7
241001553178 Arachis glabrata Species 0.000 description 7
102000004961 Furin Human genes 0.000 description 7
108090001126 Furin Proteins 0.000 description 7
108090001074 Nucleocapsid Proteins Proteins 0.000 description 7
241001112090 Pseudovirus Species 0.000 description 7
241000700605 Viruses Species 0.000 description 7
239000004480 active ingredient Substances 0.000 description 7
238000007792 addition Methods 0.000 description 7
230000000890 antigenic effect Effects 0.000 description 7
229910052799 carbon Inorganic materials 0.000 description 7
238000003776 cleavage reaction Methods 0.000 description 7
229940104302 cytosine Drugs 0.000 description 7
OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 7
230000014509 gene expression Effects 0.000 description 7
230000002209 hydrophobic effect Effects 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
125000005647 linker group Chemical group 0.000 description 7
239000012528 membrane Substances 0.000 description 7
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 7
239000000178 monomer Substances 0.000 description 7
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
239000010452 phosphate Substances 0.000 description 7
235000021317 phosphate Nutrition 0.000 description 7
239000001294 propane Substances 0.000 description 7
HTUIWRWYYVBCFT-UHFFFAOYSA-N propyl hexanoate Chemical compound CCCCCC(=O)OCCC HTUIWRWYYVBCFT-UHFFFAOYSA-N 0.000 description 7
102200056390 rs12204826 Human genes 0.000 description 7
230000007017 scission Effects 0.000 description 7
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
229940045145 uridine Drugs 0.000 description 7
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
229930024421 Adenine Natural products 0.000 description 6
241000711573 Coronaviridae Species 0.000 description 6
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 6
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 6
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 6
229960000643 adenine Drugs 0.000 description 6
125000002091 cationic group Chemical group 0.000 description 6
230000008859 change Effects 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
239000003814 drug Substances 0.000 description 6
210000001808 exosome Anatomy 0.000 description 6
235000018977 lysine Nutrition 0.000 description 6
125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
210000004379 membrane Anatomy 0.000 description 6
229910052757 nitrogen Inorganic materials 0.000 description 6
238000005457 optimization Methods 0.000 description 6
150000004713 phosphodiesters Chemical class 0.000 description 6
125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 6
230000008569 process Effects 0.000 description 6
239000000047 product Substances 0.000 description 6
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 6
102220114694 rs763810935 Human genes 0.000 description 6
239000007787 solid Substances 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
239000004471 Glycine Substances 0.000 description 5
241000282412 Homo Species 0.000 description 5
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 5
241000124008 Mammalia Species 0.000 description 5
102000018697 Membrane Proteins Human genes 0.000 description 5
108010052285 Membrane Proteins Proteins 0.000 description 5
241000699670 Mus sp. Species 0.000 description 5
108091093037 Peptide nucleic acid Proteins 0.000 description 5
239000004698 Polyethylene Substances 0.000 description 5
239000002202 Polyethylene glycol Substances 0.000 description 5
102220642430 Spindlin-1_P681R_mutation Human genes 0.000 description 5
230000002776 aggregation Effects 0.000 description 5
238000004220 aggregation Methods 0.000 description 5
125000000217 alkyl group Chemical group 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
230000015556 catabolic process Effects 0.000 description 5
230000001413 cellular effect Effects 0.000 description 5
229960001231 choline Drugs 0.000 description 5
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 5
238000006731 degradation reaction Methods 0.000 description 5
MWRBNPKJOOWZPW-CLFAGFIQSA-N dioleoyl phosphatidylethanolamine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-CLFAGFIQSA-N 0.000 description 5
125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
238000001990 intravenous administration Methods 0.000 description 5
230000003278 mimic effect Effects 0.000 description 5
DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 5
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 5
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 5
235000019260 propionic acid Nutrition 0.000 description 5
229920002477 rna polymer Polymers 0.000 description 5
HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 5
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 5
SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 4
LVNGJLRDBYCPGB-UHFFFAOYSA-N 1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-UHFFFAOYSA-N 0.000 description 4
HXVVOLDXHIMZJZ-UHFFFAOYSA-N 3-[2-[2-[2-[bis[3-(dodecylamino)-3-oxopropyl]amino]ethyl-[3-(dodecylamino)-3-oxopropyl]amino]ethylamino]ethyl-[3-(dodecylamino)-3-oxopropyl]amino]-n-dodecylpropanamide Chemical compound CCCCCCCCCCCCNC(=O)CCN(CCC(=O)NCCCCCCCCCCCC)CCN(CCC(=O)NCCCCCCCCCCCC)CCNCCN(CCC(=O)NCCCCCCCCCCCC)CCC(=O)NCCCCCCCCCCCC HXVVOLDXHIMZJZ-UHFFFAOYSA-N 0.000 description 4
PEHVGBZKEYRQSX-UHFFFAOYSA-N 7-deaza-adenine Chemical compound NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 4
HCGHYQLFMPXSDU-UHFFFAOYSA-N 7-methyladenine Chemical compound C1=NC(N)=C2N(C)C=NC2=N1 HCGHYQLFMPXSDU-UHFFFAOYSA-N 0.000 description 4
239000002126 C01EB10 - Adenosine Substances 0.000 description 4
102000053602 DNA Human genes 0.000 description 4
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
239000004472 Lysine Substances 0.000 description 4
229920002560 Polyethylene Glycol 3000 Polymers 0.000 description 4
102220599406 Spindlin-1_N501Y_mutation Human genes 0.000 description 4
JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 4
230000002378 acidificating effect Effects 0.000 description 4
239000013543 active substance Substances 0.000 description 4
229960005305 adenosine Drugs 0.000 description 4
235000003704 aspartic acid Nutrition 0.000 description 4
239000002585 base Substances 0.000 description 4
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
238000004422 calculation algorithm Methods 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
230000034994 death Effects 0.000 description 4
231100000517 death Toxicity 0.000 description 4
RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 4
125000000524 functional group Chemical group 0.000 description 4
210000003494 hepatocyte Anatomy 0.000 description 4
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
239000007791 liquid phase Substances 0.000 description 4
229920001427 mPEG Polymers 0.000 description 4
210000000066 myeloid cell Anatomy 0.000 description 4
NFQBIAXADRDUGK-KWXKLSQISA-N n,n-dimethyl-2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/C\C=C/CCCCC NFQBIAXADRDUGK-KWXKLSQISA-N 0.000 description 4
GLGLUQVVDHRLQK-WRBBJXAJSA-N n,n-dimethyl-2,3-bis[(z)-octadec-9-enoxy]propan-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/CCCCCCCC GLGLUQVVDHRLQK-WRBBJXAJSA-N 0.000 description 4
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 4
229920002523 polyethylene Glycol 1000 Polymers 0.000 description 4
FOWDZVNRQHPXDO-UHFFFAOYSA-M propyl carbonate Chemical compound CCCOC([O-])=O FOWDZVNRQHPXDO-UHFFFAOYSA-M 0.000 description 4
238000004007 reversed phase HPLC Methods 0.000 description 4
102200059763 rs28942096 Human genes 0.000 description 4
229960001153 serine Drugs 0.000 description 4
239000007790 solid phase Substances 0.000 description 4
241000894007 species Species 0.000 description 4
238000007920 subcutaneous administration Methods 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
230000032258 transport Effects 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 3
UVBYMVOUBXYSFV-XUTVFYLZSA-N 1-methylpseudouridine Chemical compound O=C1NC(=O)N(C)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UVBYMVOUBXYSFV-XUTVFYLZSA-N 0.000 description 3
ZLGYVWRJIZPQMM-HHHXNRCGSA-N 2-azaniumylethyl [(2r)-2,3-di(dodecanoyloxy)propyl] phosphate Chemical compound CCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCC ZLGYVWRJIZPQMM-HHHXNRCGSA-N 0.000 description 3
GJTBSTBJLVYKAU-XVFCMESISA-N 2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C=C1 GJTBSTBJLVYKAU-XVFCMESISA-N 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
102000004127 Cytokines Human genes 0.000 description 3
108090000695 Cytokines Proteins 0.000 description 3
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
101710091045 Envelope protein Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 3
101000929928 Homo sapiens Angiotensin-converting enzyme 2 Proteins 0.000 description 3
102100034349 Integrase Human genes 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
108010089430 Phosphoproteins Proteins 0.000 description 3
101710188315 Protein X Proteins 0.000 description 3
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
108091028664 Ribonucleotide Proteins 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 3
108020004459 Small interfering RNA Proteins 0.000 description 3
102220599422 Spindlin-1_L452R_mutation Human genes 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
NRLNQCOGCKAESA-KWXKLSQISA-N [(6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl] 4-(dimethylamino)butanoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC\C=C/C\C=C/CCCCC NRLNQCOGCKAESA-KWXKLSQISA-N 0.000 description 3
NONFBHXKNNVFMO-UHFFFAOYSA-N [2-aminoethoxy(tetradecanoyloxy)phosphoryl] tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OP(=O)(OCCN)OC(=O)CCCCCCCCCCCCC NONFBHXKNNVFMO-UHFFFAOYSA-N 0.000 description 3
235000004279 alanine Nutrition 0.000 description 3
230000004075 alteration Effects 0.000 description 3
238000005571 anion exchange chromatography Methods 0.000 description 3
239000000427 antigen Substances 0.000 description 3
125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 3
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 3
MVCRZALXJBDOKF-JPZHCBQBSA-N beta-hydroxywybutosine 5'-monophosphate Chemical compound C1=NC=2C(=O)N3C(CC(O)[C@H](NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O MVCRZALXJBDOKF-JPZHCBQBSA-N 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
238000013461 design Methods 0.000 description 3
VXUXKOBYNVVANW-UHFFFAOYSA-N dodecan-2-amine Chemical compound CCCCCCCCCCC(C)N VXUXKOBYNVVANW-UHFFFAOYSA-N 0.000 description 3
POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
229960003692 gamma aminobutyric acid Drugs 0.000 description 3
235000013922 glutamic acid Nutrition 0.000 description 3
239000004220 glutamic acid Substances 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
235000004554 glutamine Nutrition 0.000 description 3
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 3
102000048657 human ACE2 Human genes 0.000 description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
229960003786 inosine Drugs 0.000 description 3
229960000310 isoleucine Drugs 0.000 description 3
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
239000010410 layer Substances 0.000 description 3
239000002609 medium Substances 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
150000008104 phosphatidylethanolamines Chemical class 0.000 description 3
102000028499 poly(A) binding Human genes 0.000 description 3
108091023021 poly(A) binding Proteins 0.000 description 3
230000004481 post-translational protein modification Effects 0.000 description 3
OVFMRFMJVFDSAA-UHFFFAOYSA-N propyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC OVFMRFMJVFDSAA-UHFFFAOYSA-N 0.000 description 3
239000002336 ribonucleotide Substances 0.000 description 3
125000002652 ribonucleotide group Chemical group 0.000 description 3
239000000523 sample Substances 0.000 description 3
238000000926 separation method Methods 0.000 description 3
239000004055 small Interfering RNA Substances 0.000 description 3
SRLOHQKOADWDBV-NRONOFSHSA-M sodium;[(2r)-2,3-di(octadecanoyloxy)propyl] 2-(2-methoxyethoxycarbonylamino)ethyl phosphate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC SRLOHQKOADWDBV-NRONOFSHSA-M 0.000 description 3
125000006850 spacer group Chemical group 0.000 description 3
229910052717 sulfur Inorganic materials 0.000 description 3
239000000725 suspension Substances 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
239000001226 triphosphate Substances 0.000 description 3
238000000108 ultra-filtration Methods 0.000 description 3
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 3
125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
DFLGHUGIWAYXFV-XVTLYKPTSA-N (12z,15z)-n,n-dimethylhenicosa-12,15-dien-4-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(N(C)C)CCC DFLGHUGIWAYXFV-XVTLYKPTSA-N 0.000 description 2
VKRSOPFWJRDTME-HDXUUTQWSA-N (13z,16z)-n,n-dimethyldocosa-13,16-dien-5-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(N(C)C)CCCC VKRSOPFWJRDTME-HDXUUTQWSA-N 0.000 description 2
BZZLBAMHZHKRFK-XVTLYKPTSA-N (14z,17z)-n,n-dimethyltricosa-14,17-dien-4-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(N(C)C)CCC BZZLBAMHZHKRFK-XVTLYKPTSA-N 0.000 description 2
GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 2
NYRYVZIUPOHALZ-QGLGPCELSA-N (15z,18z)-n,n-dimethyltetracosa-15,18-dien-7-amine Chemical compound CCCCCCC(N(C)C)CCCCCCC\C=C/C\C=C/CCCCC NYRYVZIUPOHALZ-QGLGPCELSA-N 0.000 description 2
DELUIQJQMCTOCD-HDXUUTQWSA-N (16z,19z)-n,n-dimethylpentacosa-16,19-dien-6-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(N(C)C)CCCCC DELUIQJQMCTOCD-HDXUUTQWSA-N 0.000 description 2
ZFQNFOUTWXVNBG-QGLGPCELSA-N (19z,22z)-n,n-dimethyloctacosa-19,22-dien-7-amine Chemical compound CCCCCCC(N(C)C)CCCCCCCCCCC\C=C/C\C=C/CCCCC ZFQNFOUTWXVNBG-QGLGPCELSA-N 0.000 description 2
POBBAOCNGBEZJQ-AUGURXLVSA-N (20z,23z)-n,n-dimethylnonacosa-20,23-dien-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCC\C=C/C\C=C/CCCCC POBBAOCNGBEZJQ-AUGURXLVSA-N 0.000 description 2
IHKVCZISZBWDEJ-NFYLBXPESA-N (20z,23z)-n-ethyl-n-methylnonacosa-20,23-dien-10-amine Chemical compound CCCCCCCCCC(N(C)CC)CCCCCCCCC\C=C/C\C=C/CCCCC IHKVCZISZBWDEJ-NFYLBXPESA-N 0.000 description 2
FVHCEZRYPCZLAX-AUGURXLVSA-N (22z,25z)-n,n-dimethylhentriaconta-22,25-dien-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCCC\C=C/C\C=C/CCCCC FVHCEZRYPCZLAX-AUGURXLVSA-N 0.000 description 2
YIMATHOGWXZHFX-WCTZXXKLSA-N (2r,3r,4r,5r)-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolane-2,4-diol Chemical compound COCCO[C@H]1[C@H](O)O[C@H](CO)[C@H]1O YIMATHOGWXZHFX-WCTZXXKLSA-N 0.000 description 2
KYJLJOJCMUFWDY-UUOKFMHZSA-N (2r,3r,4s,5r)-2-(6-amino-8-azidopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound [N-]=[N+]=NC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O KYJLJOJCMUFWDY-UUOKFMHZSA-N 0.000 description 2
OPCHFPHZPIURNA-MFERNQICSA-N (2s)-2,5-bis(3-aminopropylamino)-n-[2-(dioctadecylamino)acetyl]pentanamide Chemical compound CCCCCCCCCCCCCCCCCCN(CC(=O)NC(=O)[C@H](CCCNCCCN)NCCCN)CCCCCCCCCCCCCCCCCC OPCHFPHZPIURNA-MFERNQICSA-N 0.000 description 2
WKJDWDLHIOUPPL-JSOSNVBQSA-N (2s)-2-amino-3-({[(2r)-2,3-bis(tetradecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCC WKJDWDLHIOUPPL-JSOSNVBQSA-N 0.000 description 2
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
MISZWZHGSSSVEE-MSUUIHNZSA-N (z)-n,n-dimethylhentriacont-22-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCCC\C=C/CCCCCCCC MISZWZHGSSSVEE-MSUUIHNZSA-N 0.000 description 2
SDJYFFRZEJMSHR-MSUUIHNZSA-N (z)-n,n-dimethylheptacos-18-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCC\C=C/CCCCCCCC SDJYFFRZEJMSHR-MSUUIHNZSA-N 0.000 description 2
YULDRMDDVGOLRP-MSUUIHNZSA-N (z)-n,n-dimethylhexacos-17-en-9-amine Chemical compound CCCCCCCC\C=C/CCCCCCCC(N(C)C)CCCCCCCC YULDRMDDVGOLRP-MSUUIHNZSA-N 0.000 description 2
VAEPXOIOCOVXOD-GYHWCHFESA-N (z)-n,n-dimethylnonacos-14-en-10-amine Chemical compound CCCCCCCCCCCCCC\C=C/CCCC(N(C)C)CCCCCCCCC VAEPXOIOCOVXOD-GYHWCHFESA-N 0.000 description 2
PKPFJIXXVGJSKM-NXVVXOECSA-N (z)-n,n-dimethylpentacos-16-en-8-amine Chemical compound CCCCCCCC\C=C/CCCCCCCC(N(C)C)CCCCCCC PKPFJIXXVGJSKM-NXVVXOECSA-N 0.000 description 2
CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 description 2
FVXDQWZBHIXIEJ-LNDKUQBDSA-N 1,2-di-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC FVXDQWZBHIXIEJ-LNDKUQBDSA-N 0.000 description 2
SLKDGVPOSSLUAI-PGUFJCEWSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC SLKDGVPOSSLUAI-PGUFJCEWSA-N 0.000 description 2
PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 2
TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
BIABMEZBCHDPBV-MPQUPPDSSA-N 1,2-palmitoyl-sn-glycero-3-phospho-(1'-sn-glycerol) Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@@H](O)CO)OC(=O)CCCCCCCCCCCCCCC BIABMEZBCHDPBV-MPQUPPDSSA-N 0.000 description 2
CIGFGRPIZLSWJD-HDXUUTQWSA-N 1-[(20z,23z)-nonacosa-20,23-dien-10-yl]pyrrolidine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(CCCCCCCCC)N1CCCC1 CIGFGRPIZLSWJD-HDXUUTQWSA-N 0.000 description 2
PLKOSISDOAHHCI-QYCRHRGJSA-N 1-[2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propyl]-4-methylpiperazine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCC(OCCCCCCCC\C=C/C\C=C/CCCCC)CN1CCN(C)CC1 PLKOSISDOAHHCI-QYCRHRGJSA-N 0.000 description 2
UVBYMVOUBXYSFV-UHFFFAOYSA-N 1-methylpseudouridine Natural products O=C1NC(=O)N(C)C=C1C1C(O)C(O)C(CO)O1 UVBYMVOUBXYSFV-UHFFFAOYSA-N 0.000 description 2
QUKPALAWEPMWOS-UHFFFAOYSA-N 1h-pyrazolo[3,4-d]pyrimidine Chemical class C1=NC=C2C=NNC2=N1 QUKPALAWEPMWOS-UHFFFAOYSA-N 0.000 description 2
LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 2
KWVJHCQQUFDPLU-YEUCEMRASA-N 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KWVJHCQQUFDPLU-YEUCEMRASA-N 0.000 description 2
239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 2
QJWLXRCSILVSPL-CLFAGFIQSA-N 2-[bis[(z)-octadec-9-enyl]amino]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCN(CCO)CCCCCCCC\C=C/CCCCCCCC QJWLXRCSILVSPL-CLFAGFIQSA-N 0.000 description 2
JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 2
FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
VZQXUWKZDSEQRR-SDBHATRESA-N 2-methylthio-N(6)-(Delta(2)-isopentenyl)adenosine Chemical compound C12=NC(SC)=NC(NCC=C(C)C)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VZQXUWKZDSEQRR-SDBHATRESA-N 0.000 description 2
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
BINGDNLMMYSZFR-QYVSTXNMSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,7-dimethyl-5h-imidazo[1,2-a]purin-9-one Chemical compound C1=NC=2C(=O)N3C(C)=C(C)N=C3NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O BINGDNLMMYSZFR-QYVSTXNMSA-N 0.000 description 2
DIIXYZRGUJMAPE-KWXKLSQISA-N 3-[(6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl]oxy-n,n-dimethylpropan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(OCCCN(C)C)CCCCCCCC\C=C/C\C=C/CCCCC DIIXYZRGUJMAPE-KWXKLSQISA-N 0.000 description 2
OFNURJYUSVVJPM-UHFFFAOYSA-N 3-octylundecanoic acid Chemical compound CCCCCCCCC(CC(O)=O)CCCCCCCC OFNURJYUSVVJPM-UHFFFAOYSA-N 0.000 description 2
RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
KQOYZXMRNJNKNZ-UHFFFAOYSA-N 4,4-dioctoxybutanoic acid Chemical compound C(CCCCCCC)OC(CCC(=O)O)OCCCCCCCC KQOYZXMRNJNKNZ-UHFFFAOYSA-N 0.000 description 2
UFQDKRWQSFLPQY-UHFFFAOYSA-N 4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound Cl.C1CN=CN1 UFQDKRWQSFLPQY-UHFFFAOYSA-N 0.000 description 2
QUZQVVNSDQCAOL-WOUKDFQISA-N 4-demethylwyosine Chemical compound N1C(C)=CN(C(C=2N=C3)=O)C1=NC=2N3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QUZQVVNSDQCAOL-WOUKDFQISA-N 0.000 description 2
OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 2
VSCNRXVDHRNJOA-PNHWDRBUSA-N 5-(carboxymethylaminomethyl)uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CNCC(O)=O)=C1 VSCNRXVDHRNJOA-PNHWDRBUSA-N 0.000 description 2
RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-(hydroxymethyl)cytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 description 2
QXDXBKZJFLRLCM-UAKXSSHOSA-N 5-hydroxyuridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(O)=C1 QXDXBKZJFLRLCM-UAKXSSHOSA-N 0.000 description 2
YIZYCHKPHCPKHZ-PNHWDRBUSA-N 5-methoxycarbonylmethyluridine Chemical compound O=C1NC(=O)C(CC(=O)OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YIZYCHKPHCPKHZ-PNHWDRBUSA-N 0.000 description 2
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical class CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 2
LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 2
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
102220621765 AP-3 complex subunit beta-1_Q57H_mutation Human genes 0.000 description 2
102220579649 ATP-dependent RNA helicase A_K417N_mutation Human genes 0.000 description 2
108020005176 AU Rich Elements Proteins 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 description 2
108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 2
241000272517 Anseriformes Species 0.000 description 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000271566 Aves Species 0.000 description 2
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 2
NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
KLFKZIQAIPDJCW-HTIIIDOHSA-N Dipalmitoylphosphatidylserine Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCC KLFKZIQAIPDJCW-HTIIIDOHSA-N 0.000 description 2
108010016626 Dipeptides Proteins 0.000 description 2
206010013975 Dyspnoeas Diseases 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
239000005977 Ethylene Substances 0.000 description 2
108060002716 Exonuclease Proteins 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
108091093094 Glycol nucleic acid Proteins 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
229930010555 Inosine Natural products 0.000 description 2
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
102000004388 Interleukin-4 Human genes 0.000 description 2
108091092195 Intron Proteins 0.000 description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
ZKZBPNGNEQAJSX-REOHCLBHSA-N L-selenocysteine Chemical compound [SeH]C[C@H](N)C(O)=O ZKZBPNGNEQAJSX-REOHCLBHSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
239000000232 Lipid Bilayer Substances 0.000 description 2
ZBYRSRLCXTUFLJ-IOSLPCCCSA-O N(2),N(7)-dimethylguanosine Chemical compound CNC=1NC(C=2[N+](=CN([C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)C=2N=1)C)=O ZBYRSRLCXTUFLJ-IOSLPCCCSA-O 0.000 description 2
VQAYFKKCNSOZKM-IOSLPCCCSA-N N(6)-methyladenosine Chemical compound C1=NC=2C(NC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VQAYFKKCNSOZKM-IOSLPCCCSA-N 0.000 description 2
229920002505 N-(Carbonyl-Methoxypolyethylene Glycol 2000)-1,2-Distearoyl-Sn-Glycero-3-Phosphoethanolamine Polymers 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 2
REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
239000005642 Oleic acid Substances 0.000 description 2
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
108700026244 Open Reading Frames Proteins 0.000 description 2
102000007982 Phosphoproteins Human genes 0.000 description 2
229920000362 Polyethylene-block-poly(ethylene glycol) Polymers 0.000 description 2
229920002873 Polyethylenimine Polymers 0.000 description 2
229930185560 Pseudouridine Natural products 0.000 description 2
PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 2
108091000106 RNA cap binding Proteins 0.000 description 2
102000028391 RNA cap binding Human genes 0.000 description 2
230000009948 RNA mutation Effects 0.000 description 2
108091005774 SARS-CoV-2 proteins Proteins 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
101000953880 Severe acute respiratory syndrome coronavirus 2 Membrane protein Proteins 0.000 description 2
101000779242 Severe acute respiratory syndrome coronavirus 2 ORF3a protein Proteins 0.000 description 2
102220590697 Spindlin-1_A67V_mutation Human genes 0.000 description 2
102220599627 Spindlin-1_D950N_mutation Human genes 0.000 description 2
102220590604 Spindlin-1_K417N_mutation Human genes 0.000 description 2
102220599614 Spindlin-1_Q677H_mutation Human genes 0.000 description 2
102220590621 Spindlin-1_T19R_mutation Human genes 0.000 description 2
102220599418 Spindlin-1_V1176F_mutation Human genes 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
YXNIEZJFCGTDKV-UHFFFAOYSA-N X-Nucleosid Natural products O=C1N(CCC(N)C(O)=O)C(=O)C=CN1C1C(O)C(O)C(CO)O1 YXNIEZJFCGTDKV-UHFFFAOYSA-N 0.000 description 2
DSNRWDQKZIEDDB-GCMPNPAFSA-N [(2r)-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC DSNRWDQKZIEDDB-GCMPNPAFSA-N 0.000 description 2
ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 2
229960000583 acetic acid Drugs 0.000 description 2
235000011054 acetic acid Nutrition 0.000 description 2
230000004913 activation Effects 0.000 description 2
238000001261 affinity purification Methods 0.000 description 2
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 2
229940077484 ammonium bromide Drugs 0.000 description 2
125000000129 anionic group Chemical group 0.000 description 2
OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 description 2
125000004104 aryloxy group Chemical group 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
239000011324 bead Substances 0.000 description 2
WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
SVGGKWILBMPIJV-UHFFFAOYSA-N butyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCCCC SVGGKWILBMPIJV-UHFFFAOYSA-N 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
102220364503 c.245T>C Human genes 0.000 description 2
102220429344 c.456G>T Human genes 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
238000005251 capillar electrophoresis Methods 0.000 description 2
238000001818 capillary gel electrophoresis Methods 0.000 description 2
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
229940106189 ceramide Drugs 0.000 description 2
210000001175 cerebrospinal fluid Anatomy 0.000 description 2
150000001841 cholesterols Chemical class 0.000 description 2
WLNARFZDISHUGS-MIXBDBMTSA-N cholesteryl hemisuccinate Chemical compound C1C=C2C[C@@H](OC(=O)CCC(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 WLNARFZDISHUGS-MIXBDBMTSA-N 0.000 description 2
GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 2
238000004590 computer program Methods 0.000 description 2
239000000356 contaminant Substances 0.000 description 2
125000004122 cyclic group Chemical group 0.000 description 2
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000000432 density-gradient centrifugation Methods 0.000 description 2
229940093541 dicetylphosphate Drugs 0.000 description 2
238000001085 differential centrifugation Methods 0.000 description 2
ZPTBLXKRQACLCR-XVFCMESISA-N dihydrouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)CC1 ZPTBLXKRQACLCR-XVFCMESISA-N 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 2
229960003724 dimyristoylphosphatidylcholine Drugs 0.000 description 2
229960005160 dimyristoylphosphatidylglycerol Drugs 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
239000002612 dispersion medium Substances 0.000 description 2
BPHQZTVXXXJVHI-AJQTZOPKSA-N ditetradecanoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@@H](O)CO)OC(=O)CCCCCCCCCCCCC BPHQZTVXXXJVHI-AJQTZOPKSA-N 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000013504 emergency use authorization Methods 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
230000012202 endocytosis Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
PUSKHXMZPOMNTQ-UHFFFAOYSA-N ethyl 2,1,3-benzoselenadiazole-5-carboxylate Chemical compound CCOC(=O)C1=CC=C2N=[Se]=NC2=C1 PUSKHXMZPOMNTQ-UHFFFAOYSA-N 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
102000013165 exonuclease Human genes 0.000 description 2
210000003608 fece Anatomy 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000000684 flow cytometry Methods 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000007306 functionalization reaction Methods 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
229960004956 glycerylphosphorylcholine Drugs 0.000 description 2
125000001475 halogen functional group Chemical group 0.000 description 2
125000005843 halogen group Chemical group 0.000 description 2
OAMFFXYYHGUAEQ-UHFFFAOYSA-N henicosan-10-amine Chemical compound CCCCCCCCCCCC(N)CCCCCCCCC OAMFFXYYHGUAEQ-UHFFFAOYSA-N 0.000 description 2
CKDDRHZIAZRDBW-UHFFFAOYSA-M henicosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCC([O-])=O CKDDRHZIAZRDBW-UHFFFAOYSA-M 0.000 description 2
MHRITDAIAZETRS-UHFFFAOYSA-N hexadecan-8-amine Chemical compound CCCCCCCCC(N)CCCCCCC MHRITDAIAZETRS-UHFFFAOYSA-N 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
239000003547 immunosorbent Substances 0.000 description 2
230000000415 inactivating effect Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000000185 intracerebroventricular administration Methods 0.000 description 2
238000007913 intrathecal administration Methods 0.000 description 2
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
239000002479 lipoplex Substances 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
230000004807 localization Effects 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
150000002669 lysines Chemical class 0.000 description 2
KEMQGTRYUADPNZ-UHFFFAOYSA-M margarate Chemical compound CCCCCCCCCCCCCCCCC([O-])=O KEMQGTRYUADPNZ-UHFFFAOYSA-M 0.000 description 2
230000000873 masking effect Effects 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
230000034217 membrane fusion Effects 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
238000007069 methylation reaction Methods 0.000 description 2
239000000693 micelle Substances 0.000 description 2
RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
238000010172 mouse model Methods 0.000 description 2
210000003097 mucus Anatomy 0.000 description 2
229940031348 multivalent vaccine Drugs 0.000 description 2
210000000663 muscle cell Anatomy 0.000 description 2
KHGRPHJXYWLEFQ-HKTUAWPASA-N n,n-dimethyl-2,3-bis[(9z,12z,15z)-octadeca-9,12,15-trienoxy]propan-1-amine Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/C\C=C/C\C=C/CC KHGRPHJXYWLEFQ-HKTUAWPASA-N 0.000 description 2
229940078490 n,n-dimethylglycine Drugs 0.000 description 2
FZZRQGRMBHTCSF-UHFFFAOYSA-N n,n-dimethylheptacosan-10-amine Chemical compound CCCCCCCCCCCCCCCCCC(N(C)C)CCCCCCCCC FZZRQGRMBHTCSF-UHFFFAOYSA-N 0.000 description 2
YNTOKMNHRPSGFU-UHFFFAOYSA-N n-Propyl carbamate Chemical compound CCCOC(N)=O YNTOKMNHRPSGFU-UHFFFAOYSA-N 0.000 description 2
DEKCSXCNXGALFT-UHFFFAOYSA-N nonadecan-10-amine Chemical compound CCCCCCCCCC(N)CCCCCCCCC DEKCSXCNXGALFT-UHFFFAOYSA-N 0.000 description 2
125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
GOLAKLHPPDDLST-UHFFFAOYSA-N octadeca-9,12-dien-1-amine Chemical compound CCCCCC=CCC=CCCCCCCCCN GOLAKLHPPDDLST-UHFFFAOYSA-N 0.000 description 2
125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 2
229960002969 oleic acid Drugs 0.000 description 2
235000021313 oleic acid Nutrition 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
SECPZKHBENQXJG-FPLPWBNLSA-M palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC([O-])=O SECPZKHBENQXJG-FPLPWBNLSA-M 0.000 description 2
230000006320 pegylation Effects 0.000 description 2
NTPSQPZXFVRULZ-UHFFFAOYSA-N pentadecan-8-amine Chemical compound CCCCCCCC(N)CCCCCCC NTPSQPZXFVRULZ-UHFFFAOYSA-N 0.000 description 2
125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
150000002972 pentoses Chemical class 0.000 description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
150000008298 phosphoramidates Chemical class 0.000 description 2
150000003013 phosphoric acid derivatives Chemical group 0.000 description 2
DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
229920001451 polypropylene glycol Polymers 0.000 description 2
210000004909 pre-ejaculatory fluid Anatomy 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
IXRIKXJQFYIWSW-UHFFFAOYSA-N propan-1-one Chemical compound CC[C+]=O IXRIKXJQFYIWSW-UHFFFAOYSA-N 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
108020001580 protein domains Proteins 0.000 description 2
229940096913 pseudoisocytidine Drugs 0.000 description 2
PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 2
238000000275 quality assurance Methods 0.000 description 2
238000003908 quality control method Methods 0.000 description 2
238000011002 quantification Methods 0.000 description 2
230000009467 reduction Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
239000002342 ribonucleoside Substances 0.000 description 2
102220223340 rs1060502592 Human genes 0.000 description 2
102220277043 rs1553408229 Human genes 0.000 description 2
102220075059 rs529697285 Human genes 0.000 description 2
102220046173 rs587782706 Human genes 0.000 description 2
102220058658 rs771746264 Human genes 0.000 description 2
102220074121 rs796052019 Human genes 0.000 description 2
RHFUOMFWUGWKKO-UHFFFAOYSA-N s2C Natural products S=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 RHFUOMFWUGWKKO-UHFFFAOYSA-N 0.000 description 2
229940055619 selenocysteine Drugs 0.000 description 2
ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 2
235000016491 selenocysteine Nutrition 0.000 description 2
238000001542 size-exclusion chromatography Methods 0.000 description 2
238000010532 solid phase synthesis reaction Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
125000001424 substituent group Chemical group 0.000 description 2
125000000547 substituted alkyl group Chemical group 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000011593 sulfur Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
XEVMVGUAJRGPOM-UHFFFAOYSA-N tetradecan-5-amine Chemical compound CCCCCCCCCC(N)CCCC XEVMVGUAJRGPOM-UHFFFAOYSA-N 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
230000008719 thickening Effects 0.000 description 2
239000002562 thickening agent Substances 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000010361 transduction Methods 0.000 description 2
230000026683 transduction Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
108010027510 vaccinia virus capping enzyme Proteins 0.000 description 2
239000004474 valine Substances 0.000 description 2
229960003636 vidarabine Drugs 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
230000008673 vomiting Effects 0.000 description 2
QDNMNPIKMDQXBS-QYCRHRGJSA-N (1-methylpiperidin-3-yl)methyl n,n-bis[(11z,14z)-icosa-11,14-dienyl]carbamate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCCN(CCCCCCCCCC\C=C/C\C=C/CCCCC)C(=O)OCC1CCCN(C)C1 QDNMNPIKMDQXBS-QYCRHRGJSA-N 0.000 description 1
KZIQWSQXCKPZBG-KWXKLSQISA-N (11Z,14Z)-2-(dimethylamino)-2-[(9Z,12Z)-octadeca-9,12-dienyl]icosa-11,14-dien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(CO)(CCCCCCCC\C=C/C\C=C/CCCCC)N(C)C KZIQWSQXCKPZBG-KWXKLSQISA-N 0.000 description 1
ZVHQZRCZIGWAJW-PCNZSISYSA-N (11e,20z,23z)-n,n-dimethylnonacosa-11,20,23-trien-10-amine Chemical compound CCCCCCCCCC(N(C)C)\C=C\CCCCCCC\C=C/C\C=C/CCCCC ZVHQZRCZIGWAJW-PCNZSISYSA-N 0.000 description 1
MRGAZQLDRACERW-HDXUUTQWSA-N (14z,17z)-n,n-dimethyltricosa-14,17-dien-6-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(N(C)C)CCCCC MRGAZQLDRACERW-HDXUUTQWSA-N 0.000 description 1
BZRXZULJYFAROV-HDXUUTQWSA-N (15z,18z)-n,n-dimethyltetracosa-15,18-dien-5-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(N(C)C)CCCC BZRXZULJYFAROV-HDXUUTQWSA-N 0.000 description 1
DGQYVBDAVMYDJC-QGLGPCELSA-N (17z,20z)-n,n-dimethylhexacosa-17,20-dien-7-amine Chemical compound CCCCCCC(N(C)C)CCCCCCCCC\C=C/C\C=C/CCCCC DGQYVBDAVMYDJC-QGLGPCELSA-N 0.000 description 1
FFEFKDZFCYQVMR-AUGURXLVSA-N (18z,21z)-n,n-dimethylheptacosa-18,21-dien-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCC\C=C/C\C=C/CCCCC FFEFKDZFCYQVMR-AUGURXLVSA-N 0.000 description 1
PQCKBHAUVIAIRC-QGLGPCELSA-N (18z,21z)-n,n-dimethylheptacosa-18,21-dien-8-amine Chemical compound CCCCCCCC(N(C)C)CCCCCCCCC\C=C/C\C=C/CCCCC PQCKBHAUVIAIRC-QGLGPCELSA-N 0.000 description 1
JTERLNYVBOZRHI-PPBJBQABSA-N (2-aminoethoxy)[(2r)-2,3-bis[(5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoyloxy]propoxy]phosphinic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC JTERLNYVBOZRHI-PPBJBQABSA-N 0.000 description 1
XLKQWAMTMYIQMG-SVUPRYTISA-N (2-{[(2r)-2,3-bis[(4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC XLKQWAMTMYIQMG-SVUPRYTISA-N 0.000 description 1
YZSZLBRBVWAXFW-LNYQSQCFSA-N (2R,3R,4S,5R)-2-(2-amino-6-hydroxy-6-methoxy-3H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1(O)NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YZSZLBRBVWAXFW-LNYQSQCFSA-N 0.000 description 1
MLCOVXGRWPTYKW-JRTPCWAGSA-N (2r)-1-[(9z,12z)-octadeca-9,12-dienoxy]dodecan-2-amine Chemical compound CCCCCCCCCC[C@@H](N)COCCCCCCCC\C=C/C\C=C/CCCCC MLCOVXGRWPTYKW-JRTPCWAGSA-N 0.000 description 1
JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
MQECTKDGEQSNNL-UMCMBGNQSA-N (2r,3r,4s,5r)-2-[6-(14-aminotetradecoxyperoxyperoxyamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(NOOOOOCCCCCCCCCCCCCCN)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O MQECTKDGEQSNNL-UMCMBGNQSA-N 0.000 description 1
UUDVSZSQPFXQQM-GIWSHQQXSA-N (2r,3s,4r,5r)-2-(6-aminopurin-9-yl)-3-fluoro-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@]1(O)F UUDVSZSQPFXQQM-GIWSHQQXSA-N 0.000 description 1
RAUUWSIWMBUIDV-VTMHRMHWSA-N (2s)-1-[(13z,16z)-docosa-13,16-dienoxy]-3-hexoxy-n,n-dimethylpropan-2-amine Chemical compound CCCCCCOC[C@H](N(C)C)COCCCCCCCCCCCC\C=C/C\C=C/CCCCC RAUUWSIWMBUIDV-VTMHRMHWSA-N 0.000 description 1
IDQWWQMNLCJWBS-HAYDYOOHSA-N (2s)-1-[(9z,12z)-octadeca-9,12-dienoxy]decan-2-amine Chemical compound CCCCCCCC[C@H](N)COCCCCCCCC\C=C/C\C=C/CCCCC IDQWWQMNLCJWBS-HAYDYOOHSA-N 0.000 description 1
WJRICJOXJVMRCU-JNGRSSDXSA-N (2s)-1-[(9z,12z)-octadeca-9,12-dienoxy]nonan-2-amine Chemical compound CCCCCCC[C@H](N)COCCCCCCCC\C=C/C\C=C/CCCCC WJRICJOXJVMRCU-JNGRSSDXSA-N 0.000 description 1
UFMXQOMKWYIQDK-UVPYFLNTSA-N (2s)-1-[(9z,12z)-octadeca-9,12-dienoxy]undecan-2-amine Chemical compound CCCCCCCCC[C@H](N)COCCCCCCCC\C=C/C\C=C/CCCCC UFMXQOMKWYIQDK-UVPYFLNTSA-N 0.000 description 1
XUTPKVMBJILQJR-YSLTZPBHSA-N (2s)-1-hexoxy-3-[(11z,14z)-icosa-11,14-dienoxy]-n,n-dimethylpropan-2-amine Chemical compound CCCCCCOC[C@H](N(C)C)COCCCCCCCCCC\C=C/C\C=C/CCCCC XUTPKVMBJILQJR-YSLTZPBHSA-N 0.000 description 1
UHWVIVRBTWBYQX-XZIBJWJKSA-N (2s)-2-amino-3-hydroxy-n,n-bis[2-[(z)-octadec-9-enoxy]ethyl]propanamide Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCN(C(=O)[C@@H](N)CO)CCOCCCCCCCC\C=C/CCCCCCCC UHWVIVRBTWBYQX-XZIBJWJKSA-N 0.000 description 1
MYUOTPIQBPUQQU-CKTDUXNWSA-N (2s,3r)-2-amino-n-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-methylsulfanylpurin-6-yl]carbamoyl]-3-hydroxybutanamide Chemical compound C12=NC(SC)=NC(NC(=O)NC(=O)[C@@H](N)[C@@H](C)O)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O MYUOTPIQBPUQQU-CKTDUXNWSA-N 0.000 description 1
QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
NEWVMLLQLAGBDX-ZMGCFEEVSA-N (3r,4r)-1-methyl-3-[(z)-octadec-12-enoxy]-4-octoxypyrrolidine Chemical compound CCCCCCCCO[C@@H]1CN(C)C[C@H]1OCCCCCCCCCCC\C=C/CCCCC NEWVMLLQLAGBDX-ZMGCFEEVSA-N 0.000 description 1
SDLKJIMFLWBCHA-GJVMBIMVSA-N (3r,4r)-3,4-bis[(z)-hexadec-9-enoxy]-1-methylpyrrolidine Chemical compound CCCCCC\C=C/CCCCCCCCO[C@@H]1CN(C)C[C@H]1OCCCCCCCC\C=C/CCCCCC SDLKJIMFLWBCHA-GJVMBIMVSA-N 0.000 description 1
VBIFKRSXZKIWFS-UNGPWUORSA-N (9R)-9-[2-[3-[(dimethylamino)methyl]-5-[(3R)-3,4-di(octanoyloxy)butoxy]phenoxy]ethyl]octadecanedioic acid Chemical compound CCCCCCCC(=O)OC[C@@H](CCOC1=CC(=CC(=C1)OCC[C@H](CCCCCCCCC(=O)O)CCCCCCCC(=O)O)CN(C)C)OC(=O)CCCCCCC VBIFKRSXZKIWFS-UNGPWUORSA-N 0.000 description 1
VBIFKRSXZKIWFS-VROXBXNJSA-N (9R)-9-[2-[3-[(dimethylamino)methyl]-5-[(3S)-3,4-di(octanoyloxy)butoxy]phenoxy]ethyl]octadecanedioic acid Chemical compound CCCCCCCC(=O)OC[C@H](CCOC1=CC(=CC(=C1)OCC[C@H](CCCCCCCCC(=O)O)CCCCCCCC(=O)O)CN(C)C)OC(=O)CCCCCCC VBIFKRSXZKIWFS-VROXBXNJSA-N 0.000 description 1
PSNWQONWUAUNTD-XIMJPLDWSA-N (9Z,12Z)-19-[3-[(7Z,10Z)-18-carboxyoctadeca-7,10-dienyl]-5-[(dimethylamino)methyl]phenyl]nonadeca-9,12-dienoic acid Chemical compound CN(C)CC1=CC(=CC(=C1)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O PSNWQONWUAUNTD-XIMJPLDWSA-N 0.000 description 1
FQCRMICWSSEGOL-OIRSPXBMSA-N (9Z,12Z)-19-[3-[(7Z,10Z)-18-carboxyoctadeca-7,10-dienyl]-5-[3-(diethylamino)propoxycarbonyloxymethyl]phenyl]nonadeca-9,12-dienoic acid Chemical compound CCN(CC)CCCOC(=O)OCC1=CC(=CC(=C1)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O FQCRMICWSSEGOL-OIRSPXBMSA-N 0.000 description 1
HIMRVZSLVSNKQQ-MAZCIEHSSA-N (9Z,12Z)-N-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl]octadeca-9,12-dien-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCNCCCOCCCCCCCC\C=C/C\C=C/CCCCC HIMRVZSLVSNKQQ-MAZCIEHSSA-N 0.000 description 1
NRUKBFFXNJSWOW-QYCRHRGJSA-N (9Z,12Z)-N-methyl-N-[2-[(9Z,12Z)-octadeca-9,12-dienoxy]ethyl]octadeca-9,12-dien-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCCN(C)CCCCCCCC\C=C/C\C=C/CCCCC NRUKBFFXNJSWOW-QYCRHRGJSA-N 0.000 description 1
239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
YBCJEYSRAQIVIR-MERKUPPJSA-N (9Z,12Z,27Z,30Z)-20-(4-piperidin-1-ylbutanoyloxymethyl)nonatriaconta-9,12,27,30-tetraenedioic acid Chemical compound C1CCN(CC1)CCCC(=O)OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O YBCJEYSRAQIVIR-MERKUPPJSA-N 0.000 description 1
VWDUJAKMNCPUEL-XIMJPLDWSA-N (9Z,12Z,27Z,30Z)-20-[(1,3-dimethylpyrrolidine-3-carbonyl)oxymethyl]nonatriaconta-9,12,27,30-tetraenedioic acid Chemical compound CC1(CN(C)CC1)C(OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)=O VWDUJAKMNCPUEL-XIMJPLDWSA-N 0.000 description 1
UTQWRDGZSYSHEN-XIMJPLDWSA-N (9Z,12Z,27Z,30Z)-20-[4-(dimethylamino)butanoyloxymethyl]nonatriaconta-9,12,27,30-tetraenedioic acid Chemical compound CN(CCCC(=O)OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)C UTQWRDGZSYSHEN-XIMJPLDWSA-N 0.000 description 1
LAUDGJVOMSXMRM-MCOFMCJXSA-N (9Z,30Z)-20-[4-[3-(dimethylamino)propoxycarbonyloxy]hexadecanoyloxy]nonatriaconta-9,30-dienedioic acid Chemical compound CCCCCCCCCCCCC(OC(=O)OCCCN(C)C)CCC(=O)OC(CCCCCCCCC/C=C\CCCCCCCC(=O)O)CCCCCCCCC/C=C\CCCCCCCC(=O)O LAUDGJVOMSXMRM-MCOFMCJXSA-N 0.000 description 1
DPXUQAONLLWKDS-LTEAFHAISA-N (9z,12z)-n-[2-[(z)-octadec-9-enoxy]ethyl]octadeca-9,12-dien-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCNCCCCCCCC\C=C/C\C=C/CCCCC DPXUQAONLLWKDS-LTEAFHAISA-N 0.000 description 1
ZUVNJQGVJAFACY-QYCRHRGJSA-N (9z,12z)-n-methyl-n-[(9z,12z)-octadeca-9,12-dienyl]octadeca-9,12-dien-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCN(C)CCCCCCCC\C=C/C\C=C/CCCCC ZUVNJQGVJAFACY-QYCRHRGJSA-N 0.000 description 1
125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
LVNGJLRDBYCPGB-LDLOPFEMSA-N (R)-1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-LDLOPFEMSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
VVEGXTQSICTWOQ-WAYWQWQTSA-N (z)-1-bromonon-4-ene Chemical compound CCCC\C=C/CCCBr VVEGXTQSICTWOQ-WAYWQWQTSA-N 0.000 description 1
MTIJDFJGPCJFKE-FPLPWBNLSA-N (z)-dec-3-en-1-ol Chemical compound CCCCCC\C=C/CCO MTIJDFJGPCJFKE-FPLPWBNLSA-N 0.000 description 1
DMKFBCRXSPDHGN-PFONDFGASA-N (z)-n,n-dimethylheptacos-20-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCC\C=C/CCCCCC DMKFBCRXSPDHGN-PFONDFGASA-N 0.000 description 1
GOSOKZSRSXUCAH-VXPUYCOJSA-N (z)-n,n-dimethylnonacos-17-en-10-amine Chemical compound CCCCCCCCCCC\C=C/CCCCCCC(N(C)C)CCCCCCCCC GOSOKZSRSXUCAH-VXPUYCOJSA-N 0.000 description 1
LHULGZVVKZHNIJ-MSUUIHNZSA-N (z)-n,n-dimethylnonacos-20-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCC\C=C/CCCCCCCC LHULGZVVKZHNIJ-MSUUIHNZSA-N 0.000 description 1
PPDDFVKQPSPFAB-MSUUIHNZSA-N (z)-n,n-dimethyltritriacont-24-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCCCCC\C=C/CCCCCCCC PPDDFVKQPSPFAB-MSUUIHNZSA-N 0.000 description 1
FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical compound C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
SSCDRSKJTAQNNB-DWEQTYCFSA-N 1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC SSCDRSKJTAQNNB-DWEQTYCFSA-N 0.000 description 1
LZLVZIFMYXDKCN-QJWFYWCHSA-N 1,2-di-O-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC LZLVZIFMYXDKCN-QJWFYWCHSA-N 0.000 description 1
XXKFQTJOJZELMD-JICBSJGISA-N 1,2-di-[(9Z,12Z,15Z)-octadecatrienoyl]-sn-glycero-3-phosphocholine Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC XXKFQTJOJZELMD-JICBSJGISA-N 0.000 description 1
WTBFLCSPLLEDEM-JIDRGYQWSA-N 1,2-dioleoyl-sn-glycero-3-phospho-L-serine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC WTBFLCSPLLEDEM-JIDRGYQWSA-N 0.000 description 1
JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 description 1
MIXBUOXRHTZHKR-XUTVFYLZSA-N 1-Methylpseudoisocytidine Chemical compound CN1C=C(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O MIXBUOXRHTZHKR-XUTVFYLZSA-N 0.000 description 1
VGHXKGWSRNEDEP-OJKLQORTSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidine-5-carboxylic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)N1C(=O)NC(=O)C(C(O)=O)=C1 VGHXKGWSRNEDEP-OJKLQORTSA-N 0.000 description 1
KYEKLQMDNZPEFU-KVTDHHQDSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)N=C1 KYEKLQMDNZPEFU-KVTDHHQDSA-N 0.000 description 1
UTQUILVPBZEHTK-ZOQUXTDFSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UTQUILVPBZEHTK-ZOQUXTDFSA-N 0.000 description 1
HXVKEKIORVUWDR-FDDDBJFASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(methylaminomethyl)-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(CNC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HXVKEKIORVUWDR-FDDDBJFASA-N 0.000 description 1
KJLRIEFCMSGNSI-HKUMRIAESA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(3-methylbut-3-enylamino)methyl]-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(CNCCC(=C)C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 KJLRIEFCMSGNSI-HKUMRIAESA-N 0.000 description 1
HLBIEOQUEHEDCR-HKUMRIAESA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(3-methylbut-3-enylamino)methyl]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(CNCCC(=C)C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HLBIEOQUEHEDCR-HKUMRIAESA-N 0.000 description 1
RKSLVDIXBGWPIS-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 RKSLVDIXBGWPIS-UAKXSSHOSA-N 0.000 description 1
BTFXIEGOSDSOGN-KWCDMSRLSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione Chemical compound O=C1NC(=O)C(C)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 BTFXIEGOSDSOGN-KWCDMSRLSA-N 0.000 description 1
QLOCVMVCRJOTTM-TURQNECASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 QLOCVMVCRJOTTM-TURQNECASA-N 0.000 description 1
QPHRQMAYYMYWFW-FJGDRVTGSA-N 1-[(2r,3s,4r,5r)-3-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 QPHRQMAYYMYWFW-FJGDRVTGSA-N 0.000 description 1
SFJARXCDXKWUDD-MAZCIEHSSA-N 1-[3-amino-2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propyl]piperidin-4-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOC(N)C(OCCCCCCCC\C=C/C\C=C/CCCCC)CN1CCC(O)CC1 SFJARXCDXKWUDD-MAZCIEHSSA-N 0.000 description 1
QETFUWLJQVVPJW-UHFFFAOYSA-N 1-[4-[2-[2-(didodecylamino)ethyl-dodecylamino]acetyl]piperazin-1-yl]-2-[di(nonyl)amino]ethanone Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CC(=O)N1CCN(CC1)C(=O)CN(CCCCCCCCC)CCCCCCCCC QETFUWLJQVVPJW-UHFFFAOYSA-N 0.000 description 1
FVFLIHLOWLUEPP-UHFFFAOYSA-N 1-[4-[2-[2-(didodecylamino)ethyl-nonylamino]acetyl]piperazin-1-yl]-2-[di(nonyl)amino]ethanone Chemical compound C(CCCCCCCCCCC)N(CCN(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCC)CCCCCCCCC)=O)CCCCCCCCC)CCCCCCCCCCCC FVFLIHLOWLUEPP-UHFFFAOYSA-N 0.000 description 1
QZQDTRSJACDICN-UHFFFAOYSA-N 1-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-[di(tetradecyl)amino]ethanone Chemical compound C(CCCCCCCC)N(CCN(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCCCCCCC)CCCCCCCCCCCCCC)=O)CCCCCCCCC)CCCCCCCCC QZQDTRSJACDICN-UHFFFAOYSA-N 0.000 description 1
DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
VCAPOSNTDGEWSI-QYCRHRGJSA-N 1-methyl-3,3-bis[(9Z,12Z)-octadeca-9,12-dienyl]azetidine Chemical compound CN1CC(C1)(CCCCCCCC\C=C/C\C=C/CCCCC)CCCCCCCC\C=C/C\C=C/CCCCC VCAPOSNTDGEWSI-QYCRHRGJSA-N 0.000 description 1
GFYLSDSUCHVORB-IOSLPCCCSA-N 1-methyladenosine Chemical compound C1=NC=2C(=N)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O GFYLSDSUCHVORB-IOSLPCCCSA-N 0.000 description 1
UTAIYTHAJQNQDW-KQYNXXCUSA-N 1-methylguanosine Chemical compound C1=NC=2C(=O)N(C)C(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UTAIYTHAJQNQDW-KQYNXXCUSA-N 0.000 description 1
WJNGQIYEQLPJMN-IOSLPCCCSA-N 1-methylinosine Chemical compound C1=NC=2C(=O)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WJNGQIYEQLPJMN-IOSLPCCCSA-N 0.000 description 1
RUYTUSMGGNWWNM-UHFFFAOYSA-N 14-[3-(13-carboxytridecyl)-5-[(dimethylamino)methyl]phenyl]tetradecanoic acid Chemical compound CN(C)Cc1cc(CCCCCCCCCCCCCC(O)=O)cc(CCCCCCCCCCCCCC(O)=O)c1 RUYTUSMGGNWWNM-UHFFFAOYSA-N 0.000 description 1
BNGVWAFGHGJATM-UHFFFAOYSA-N 1h-imidazo[1,5-a][1,3,5]triazin-2-one Chemical class N1C(=O)N=CN2C=NC=C21 BNGVWAFGHGJATM-UHFFFAOYSA-N 0.000 description 1
UHUHBFMZVCOEOV-UHFFFAOYSA-N 1h-imidazo[4,5-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1N=CN2 UHUHBFMZVCOEOV-UHFFFAOYSA-N 0.000 description 1
HUTNOYOBQPAKIA-UHFFFAOYSA-N 1h-pyrazin-2-one Chemical class OC1=CN=CC=N1 HUTNOYOBQPAKIA-UHFFFAOYSA-N 0.000 description 1
101800001779 2'-O-methyltransferase Proteins 0.000 description 1
101800003073 2'-O-methyltransferase nsp16 Proteins 0.000 description 1
QISHSLOVZOLLQT-MAZCIEHSSA-N 2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCC(CO)OCCCCCCCC\C=C/C\C=C/CCCCC QISHSLOVZOLLQT-MAZCIEHSSA-N 0.000 description 1
UQXYRLUPQPRMDS-CLFAGFIQSA-N 2,3-bis[(z)-octadec-9-enoxy]propan-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(CN)OCCCCCCCC\C=C/CCCCCCCC UQXYRLUPQPRMDS-CLFAGFIQSA-N 0.000 description 1
WALUVDCNGPQPOD-UHFFFAOYSA-M 2,3-di(tetradecoxy)propyl-(2-hydroxyethyl)-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCOCC(C[N+](C)(C)CCO)OCCCCCCCCCCCCCC WALUVDCNGPQPOD-UHFFFAOYSA-M 0.000 description 1
RHRQNMDWDVLSMO-UHFFFAOYSA-N 2,3-didodecoxypropan-1-amine Chemical compound CCCCCCCCCCCCOCC(CN)OCCCCCCCCCCCC RHRQNMDWDVLSMO-UHFFFAOYSA-N 0.000 description 1
CRMDRQKGAQVXDC-UHFFFAOYSA-N 2,3-dioctadecoxypropan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCOCC(CN)OCCCCCCCCCCCCCCCCCC CRMDRQKGAQVXDC-UHFFFAOYSA-N 0.000 description 1
GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical compound ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 1
PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical compound NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
OHUMNVUXCKGTDQ-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-(didodecylamino)ethyl-dodecylamino]ethyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCCCCC)N(CC(=O)N1CCN(CC1)CCN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CCCCCCCCCCCC)CCCCCCCCCCCC OHUMNVUXCKGTDQ-UHFFFAOYSA-N 0.000 description 1
UGZREGJEOWUZFW-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-(didodecylamino)ethyl-nonylamino]acetyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCCCCC)N(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCC)CCN(CCCCCCCCCCCC)CCCCCCCCCCCC)=O)CCCCCCCCCCCC UGZREGJEOWUZFW-UHFFFAOYSA-N 0.000 description 1
ALWRUWFADMKTRR-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-[di(nonyl)amino]ethyl-dodecylamino]acetyl]piperazin-1-yl]ethanone Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CC(=O)N1CCN(CC1)C(=O)CN(CCCCCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC ALWRUWFADMKTRR-UHFFFAOYSA-N 0.000 description 1
WUVCFMGPLCSONQ-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCCCCC)N(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)=O)CCCCCCCCCCCC WUVCFMGPLCSONQ-UHFFFAOYSA-N 0.000 description 1
HVVSHVFVKGNRQQ-UHFFFAOYSA-N 2-(didodecylamino)-N-dodecyl-N-(2-piperazin-1-ylethyl)acetamide Chemical compound C(CCCCCCCCCCC)N(CC(=O)N(CCN1CCNCC1)CCCCCCCCCCCC)CCCCCCCCCCCC HVVSHVFVKGNRQQ-UHFFFAOYSA-N 0.000 description 1
YQFRJTDYLIBDED-UHFFFAOYSA-N 2-(didodecylamino)ethanol Chemical compound CCCCCCCCCCCCN(CCO)CCCCCCCCCCCC YQFRJTDYLIBDED-UHFFFAOYSA-N 0.000 description 1
BVLGKOVALHRKNM-XUTVFYLZSA-N 2-Thio-1-methylpseudouridine Chemical compound CN1C=C(C(=O)NC1=S)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O BVLGKOVALHRKNM-XUTVFYLZSA-N 0.000 description 1
CWXIOHYALLRNSZ-JWMKEVCDSA-N 2-Thiodihydropseudouridine Chemical compound C1C(C(=O)NC(=S)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O CWXIOHYALLRNSZ-JWMKEVCDSA-N 0.000 description 1
BFHHWEILVDOGCC-UHFFFAOYSA-N 2-[(11Z,14Z)-2-[3-(dimethylamino)propanoyloxy]icosa-11,14-dienoxy]ethyl (9Z,12Z)-octadeca-9,12-dienoate Chemical compound C(CCCCCCCC=C/CC=C/CCCCC)(=O)OCCOCC(CCCCCCCCC=C/CC=C/CCCCC)OC(CCN(C)C)=O BFHHWEILVDOGCC-UHFFFAOYSA-N 0.000 description 1
SMFNOBBHYGDJRP-MAZCIEHSSA-N 2-[(9z,12z)-octadeca-9,12-dienoxy]-n-[2-[(9z,12z)-octadeca-9,12-dienoxy]ethyl]ethanamine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCCNCCOCCCCCCCC\C=C/C\C=C/CCCCC SMFNOBBHYGDJRP-MAZCIEHSSA-N 0.000 description 1
GAJTUMASULCSDK-KTKRTIGZSA-N 2-[(Z)-octadec-9-enoxy]benzamide Chemical compound C(CCCCCCC\C=C/CCCCCCCC)OC1=C(C(=O)N)C=CC=C1 GAJTUMASULCSDK-KTKRTIGZSA-N 0.000 description 1
VNAYNYLMGVVNPX-RYOQUFEFSA-N 2-[(z)-hexadec-9-enoxy]-n-[2-[(z)-hexadec-9-enoxy]ethyl]-n-methylethanamine Chemical compound CCCCCC\C=C/CCCCCCCCOCCN(C)CCOCCCCCCCC\C=C/CCCCCC VNAYNYLMGVVNPX-RYOQUFEFSA-N 0.000 description 1
LRFJOIPOPUJUMI-KWXKLSQISA-N 2-[2,2-bis[(9z,12z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-n,n-dimethylethanamine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC1(CCCCCCCC\C=C/C\C=C/CCCCC)OCC(CCN(C)C)O1 LRFJOIPOPUJUMI-KWXKLSQISA-N 0.000 description 1
GSHCNPAEDNETGJ-HKOLQMFGSA-N 2-[2,3-bis[[(z)-octadec-9-enoyl]oxy]propoxy-ethoxyphosphoryl]oxyethyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(=O)(OCC)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC GSHCNPAEDNETGJ-HKOLQMFGSA-N 0.000 description 1
GUUGWGGRMYCWPW-UZYVYHOESA-N 2-[2-(didodecylamino)ethyl-[(Z)-dodec-6-enyl]amino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCN(CCO)CCCCC\C=C/CCCCC)CCCCCCCCCCCC GUUGWGGRMYCWPW-UZYVYHOESA-N 0.000 description 1
CKYHXQVFYSCLRY-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-dodecylamino]-1-[4-[2-(didodecylamino)ethyl]piperazin-1-yl]ethanone Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CC(=O)N1CCN(CCN(CCCCCCCCCCCC)CCCCCCCCCCCC)CC1 CKYHXQVFYSCLRY-UHFFFAOYSA-N 0.000 description 1
AGPPZXSUWFUCMR-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-dodecylamino]acetic acid Chemical compound C(CCCCCCCCCCC)N(CCN(CC(=O)O)CCCCCCCCCCCC)CCCCCCCCCCCC AGPPZXSUWFUCMR-UHFFFAOYSA-N 0.000 description 1
XCUJNEGHISWZMR-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-hexylamino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCN(CCO)CCCCCC)CCCCCCCCCCCC XCUJNEGHISWZMR-UHFFFAOYSA-N 0.000 description 1
IEZCEHHDPHPAER-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-nonylamino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCN(CCO)CCCCCCCCC)CCCCCCCCCCCC IEZCEHHDPHPAER-UHFFFAOYSA-N 0.000 description 1
NBYAZDHVBFXMCF-UHFFFAOYSA-N 2-[2-(didodecylamino)ethylamino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCNCCO)CCCCCCCCCCCC NBYAZDHVBFXMCF-UHFFFAOYSA-N 0.000 description 1
DMGKQJLIOMPVSH-BBWANDEASA-N 2-[2-[bis[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethyl-[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethanol Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)N(CCN(CCO)CCCCCCCC\C=C/C\C=C/CCCCC)CCCCCCCC\C=C/C\C=C/CCCCC DMGKQJLIOMPVSH-BBWANDEASA-N 0.000 description 1
XCGATPUUFSZPEU-ZBTSZJFVSA-N 2-[2-[bis[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethyl-dodecylamino]ethanol Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)N(CCN(CCO)CCCCCCCCCCCC)CCCCCCCC\C=C/C\C=C/CCCCC XCGATPUUFSZPEU-ZBTSZJFVSA-N 0.000 description 1
KKHRANQBFXVJMF-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-dodecylamino]ethanol Chemical compound C(CCCCCCCC)N(CCN(CCO)CCCCCCCCCCCC)CCCCCCCCC KKHRANQBFXVJMF-UHFFFAOYSA-N 0.000 description 1
XYPROMTWOHDKCL-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-nonylamino]-1-[3-[2-[di(nonyl)amino]ethyl]pyrrolidin-1-yl]ethanone Chemical compound C(CCCCCCCC)N(CCN(CC(=O)N1CC(CC1)CCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC)CCCCCCCCC XYPROMTWOHDKCL-UHFFFAOYSA-N 0.000 description 1
PWRJCIJUUCAYGV-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-nonylamino]-1-[3-[[di(nonyl)amino]methyl]pyrrolidin-1-yl]ethanone Chemical compound CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CC(=O)N1CCC(CN(CCCCCCCCC)CCCCCCCCC)C1 PWRJCIJUUCAYGV-UHFFFAOYSA-N 0.000 description 1
SFWYWCBHACRKFJ-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-nonylamino]-1-[4-[2-[di(nonyl)amino]ethyl]piperidin-1-yl]ethanone Chemical compound C(CCCCCCCC)N(CCN(CC(=O)N1CCC(CC1)CCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC)CCCCCCCCC SFWYWCBHACRKFJ-UHFFFAOYSA-N 0.000 description 1
JHMKJGRFJUTHKD-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-nonylamino]ethanol Chemical compound C(CCCCCCCC)N(CCN(CCO)CCCCCCCCC)CCCCCCCCC JHMKJGRFJUTHKD-UHFFFAOYSA-N 0.000 description 1
UERKQTLROAQDCW-UHFFFAOYSA-N 2-[2-[di(tetradecyl)amino]ethyl-tetradecylamino]ethanol Chemical compound CCCCCCCCCCCCCCN(CCO)CCN(CCCCCCCCCCCCCC)CCCCCCCCCCCCCC UERKQTLROAQDCW-UHFFFAOYSA-N 0.000 description 1
BYWPQQOQVPVCTC-UHFFFAOYSA-N 2-[3-[2-[2-[2-[2-[bis[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]ethylamino]ethyl-[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]ethylamino]ethyl-[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]propanoyloxy]ethyl 2-methyl-3-octylsulfanylpropanoate Chemical compound CCCCCCCCSCC(C)C(=O)OCCOC(=O)CCN(CCNCCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCC)CCNCCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCC BYWPQQOQVPVCTC-UHFFFAOYSA-N 0.000 description 1
PGYFLJKHWJVRMC-ZXRZDOCRSA-N 2-[4-[[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]butoxy]-n,n-dimethyl-3-[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OCCCCOC(CN(C)C)COCCCCCCCC\C=C/C\C=C/CCCCC)C1 PGYFLJKHWJVRMC-ZXRZDOCRSA-N 0.000 description 1
NUBJGTNGKODGGX-YYNOVJQHSA-N 2-[5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-1-yl]acetic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CN(CC(O)=O)C(=O)NC1=O NUBJGTNGKODGGX-YYNOVJQHSA-N 0.000 description 1
VJKJOPUEUOTEBX-TURQNECASA-N 2-[[1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]methylamino]ethanesulfonic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CNCCS(O)(=O)=O)=C1 VJKJOPUEUOTEBX-TURQNECASA-N 0.000 description 1
ACLSRRFYJWTLTP-UHFFFAOYSA-N 2-[[3-(2-carboxy-10-octanoyloxydecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-10-octanoyloxydecanoic acid Chemical compound CCCCCCCC(=O)OCCCCCCCCC(Cc1cc(CC(CCCCCCCCOC(=O)CCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O ACLSRRFYJWTLTP-UHFFFAOYSA-N 0.000 description 1
PWCAFUOPYQZCIU-UHFFFAOYSA-N 2-[[3-(2-carboxy-5-heptyldodecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-5-heptyldodecanoic acid Chemical compound CCCCCCCC(CCCCCCC)CCC(Cc1cc(CC(CCC(CCCCCCC)CCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O PWCAFUOPYQZCIU-UHFFFAOYSA-N 0.000 description 1
SRTQWXPSXCNMOZ-UHFFFAOYSA-N 2-[[3-(2-carboxy-6-nonoxycarbonyloxyhexyl)-5-[(dimethylamino)methyl]phenyl]methyl]-6-nonoxycarbonyloxyhexanoic acid Chemical compound CCCCCCCCCOC(=O)OCCCCC(Cc1cc(CC(CCCCOC(=O)OCCCCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O SRTQWXPSXCNMOZ-UHFFFAOYSA-N 0.000 description 1
INYWDMYBPAJGLJ-UHFFFAOYSA-N 2-[[3-(2-carboxy-7-hexyltridecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-7-hexyltridecanoic acid Chemical compound CCCCCCC(CCCCCC)CCCCC(Cc1cc(CC(CCCCC(CCCCCC)CCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O INYWDMYBPAJGLJ-UHFFFAOYSA-N 0.000 description 1
OZTYEKYBNLSBOX-UHFFFAOYSA-N 2-[[3-(2-carboxy-8-octanoyloxyoctyl)-5-[(dimethylamino)methyl]phenyl]methyl]-8-octanoyloxyoctanoic acid Chemical compound CCCCCCCC(=O)OCCCCCCC(Cc1cc(CC(CCCCCCOC(=O)CCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O OZTYEKYBNLSBOX-UHFFFAOYSA-N 0.000 description 1
BLAKABNCNOBITG-UHFFFAOYSA-N 2-[[3-(2-carboxy-9-pentyltetradecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-9-pentyltetradecanoic acid Chemical compound CCCCCC(CCCCC)CCCCCCC(Cc1cc(CC(CCCCCCC(CCCCC)CCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O BLAKABNCNOBITG-UHFFFAOYSA-N 0.000 description 1
LCKIHCRZXREOJU-KYXWUPHJSA-N 2-[[5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-1-yl]methylamino]ethanesulfonic acid Chemical compound C(NCCS(=O)(=O)O)N1C=C([C@H]2[C@H](O)[C@H](O)[C@@H](CO)O2)C(NC1=O)=O LCKIHCRZXREOJU-KYXWUPHJSA-N 0.000 description 1
PCHHECADXWEDRG-UHFFFAOYSA-N 2-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound CC(C)(C)[Si](C)(C)OCC(CO)(CO)CO PCHHECADXWEDRG-UHFFFAOYSA-N 0.000 description 1
JFICIOMPZTVBHD-UHFFFAOYSA-N 2-[di(nonyl)amino]-1-[4-[2-[2-[di(nonyl)amino]ethyl-dodecylamino]acetyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCC)N(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)=O)CCCCCCCCC JFICIOMPZTVBHD-UHFFFAOYSA-N 0.000 description 1
ONLQQRFLLHOAOH-UHFFFAOYSA-N 2-[di(nonyl)amino]-1-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]ethyl]piperidin-1-yl]ethanone Chemical compound C(CCCCCCCC)N(CC(=O)N1CCC(CC1)CCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC ONLQQRFLLHOAOH-UHFFFAOYSA-N 0.000 description 1
WKTZGTUUQWTJKB-UHFFFAOYSA-N 2-[di(nonyl)amino]acetaldehyde Chemical compound C(CCCCCCCC)N(CCCCCCCCC)CC=O WKTZGTUUQWTJKB-UHFFFAOYSA-N 0.000 description 1
UTQSJZGGDMBRSK-UHFFFAOYSA-N 2-[di(nonyl)amino]ethanol Chemical compound CCCCCCCCCN(CCO)CCCCCCCCC UTQSJZGGDMBRSK-UHFFFAOYSA-N 0.000 description 1
DSFMICRLIRROMX-UHFFFAOYSA-N 2-[di(tetradecyl)amino]ethanol Chemical compound CCCCCCCCCCCCCCN(CCO)CCCCCCCCCCCCCC DSFMICRLIRROMX-UHFFFAOYSA-N 0.000 description 1
VMKWCABNWIGNPN-BIXSNLIQSA-N 2-[dodecyl-[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCO)CCCCCCCC\C=C/C\C=C/CCCCC VMKWCABNWIGNPN-BIXSNLIQSA-N 0.000 description 1
VROYQGBIVAQDEG-XVTLYKPTSA-N 2-[hexyl-[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethanol Chemical compound C(CCCCC)N(CCO)CCCCCCCC\C=C/C\C=C/CCCCC VROYQGBIVAQDEG-XVTLYKPTSA-N 0.000 description 1
MPDKOGQMQLSNOF-GBNDHIKLSA-N 2-amino-5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrimidin-6-one Chemical compound O=C1NC(N)=NC=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 MPDKOGQMQLSNOF-GBNDHIKLSA-N 0.000 description 1
BIRQNXWAXWLATA-IOSLPCCCSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-1h-pyrrolo[2,3-d]pyrimidine-5-carbonitrile Chemical compound C1=C(C#N)C=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O BIRQNXWAXWLATA-IOSLPCCCSA-N 0.000 description 1
OTDJAMXESTUWLO-UUOKFMHZSA-N 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-3H-purine-6-thione Chemical compound C12=NC(N)=NC(S)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OTDJAMXESTUWLO-UUOKFMHZSA-N 0.000 description 1
HPKQEMIXSLRGJU-UUOKFMHZSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-3h-purine-6,8-dione Chemical compound O=C1N(C)C(C(NC(N)=N2)=O)=C2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HPKQEMIXSLRGJU-UUOKFMHZSA-N 0.000 description 1
BGTXMQUSDNMLDW-AEHJODJJSA-N 2-amino-9-[(2r,3s,4r,5r)-3-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@]1(O)F BGTXMQUSDNMLDW-AEHJODJJSA-N 0.000 description 1
PBFLIOAJBULBHI-JJNLEZRASA-N 2-amino-n-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]carbamoyl]acetamide Chemical compound C1=NC=2C(NC(=O)NC(=O)CN)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O PBFLIOAJBULBHI-JJNLEZRASA-N 0.000 description 1
SHCCKWGIFIPGNJ-NSUCVBPYSA-N 2-aminoethyl [(2r)-2,3-bis[(z)-octadec-9-enoxy]propyl] hydrogen phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC[C@H](COP(O)(=O)OCCN)OCCCCCCCC\C=C/CCCCCCCC SHCCKWGIFIPGNJ-NSUCVBPYSA-N 0.000 description 1
MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
XLPHMKQBBCKEFO-DHYROEPTSA-N 2-azaniumylethyl [(2r)-2,3-bis(3,7,11,15-tetramethylhexadecanoyloxy)propyl] phosphate Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CC(C)CCCC(C)CCCC(C)CCCC(C)C XLPHMKQBBCKEFO-DHYROEPTSA-N 0.000 description 1
RLZMYTZDQAVNIN-ZOQUXTDFSA-N 2-methoxy-4-thio-uridine Chemical compound COC1=NC(=S)C=CN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O RLZMYTZDQAVNIN-ZOQUXTDFSA-N 0.000 description 1
QCPQCJVQJKOKMS-VLSMUFELSA-N 2-methoxy-5-methyl-cytidine Chemical compound CC(C(N)=N1)=CN([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)C1OC QCPQCJVQJKOKMS-VLSMUFELSA-N 0.000 description 1
TUDKBZAMOFJOSO-UHFFFAOYSA-N 2-methoxy-7h-purin-6-amine Chemical compound COC1=NC(N)=C2NC=NC2=N1 TUDKBZAMOFJOSO-UHFFFAOYSA-N 0.000 description 1
STISOQJGVFEOFJ-MEVVYUPBSA-N 2-methoxy-cytidine Chemical compound COC(N([C@@H]([C@@H]1O)O[C@H](CO)[C@H]1O)C=C1)N=C1N STISOQJGVFEOFJ-MEVVYUPBSA-N 0.000 description 1
WBVPJIKOWUQTSD-ZOQUXTDFSA-N 2-methoxyuridine Chemical compound COC1=NC(=O)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 WBVPJIKOWUQTSD-ZOQUXTDFSA-N 0.000 description 1
VWSLLSXLURJCDF-UHFFFAOYSA-N 2-methyl-4,5-dihydro-1h-imidazole Chemical compound CC1=NCCN1 VWSLLSXLURJCDF-UHFFFAOYSA-N 0.000 description 1
SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
FZIIBDOXPQOKBP-UHFFFAOYSA-N 2-methyloxetane Chemical compound CC1CCO1 FZIIBDOXPQOKBP-UHFFFAOYSA-N 0.000 description 1
FXGXEFXCWDTSQK-UHFFFAOYSA-N 2-methylsulfanyl-7h-purin-6-amine Chemical compound CSC1=NC(N)=C2NC=NC2=N1 FXGXEFXCWDTSQK-UHFFFAOYSA-N 0.000 description 1
QEWSGVMSLPHELX-UHFFFAOYSA-N 2-methylthio-N6-(cis-hydroxyisopentenyl) adenosine Chemical compound C12=NC(SC)=NC(NCC=C(C)CO)=C2N=CN1C1OC(CO)C(O)C1O QEWSGVMSLPHELX-UHFFFAOYSA-N 0.000 description 1
JUMHLCXWYQVTLL-KVTDHHQDSA-N 2-thio-5-aza-uridine Chemical compound [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C(=S)NC(=O)N=C1 JUMHLCXWYQVTLL-KVTDHHQDSA-N 0.000 description 1
VRVXMIJPUBNPGH-XVFCMESISA-N 2-thio-dihydrouridine Chemical compound OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(=O)NC1=S VRVXMIJPUBNPGH-XVFCMESISA-N 0.000 description 1
ZVGONGHIVBJXFC-WCTZXXKLSA-N 2-thio-zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)N=CC=C1 ZVGONGHIVBJXFC-WCTZXXKLSA-N 0.000 description 1
RHFUOMFWUGWKKO-XVFCMESISA-N 2-thiocytidine Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RHFUOMFWUGWKKO-XVFCMESISA-N 0.000 description 1
IPMGZOSVJWTBJN-UHFFFAOYSA-N 3-(2-octadecanoyloxyethylamino)propanoic acid Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)OCCNCCC(=O)O IPMGZOSVJWTBJN-UHFFFAOYSA-N 0.000 description 1
YXNIEZJFCGTDKV-JANFQQFMSA-N 3-(3-amino-3-carboxypropyl)uridine Chemical compound O=C1N(CCC(N)C(O)=O)C(=O)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YXNIEZJFCGTDKV-JANFQQFMSA-N 0.000 description 1
MVJKYYXKLCTVHV-UHFFFAOYSA-N 3-(didodecylamino)propan-1-ol Chemical compound CCCCCCCCCCCCN(CCCO)CCCCCCCCCCCC MVJKYYXKLCTVHV-UHFFFAOYSA-N 0.000 description 1
RDPUKVRQKWBSPK-UHFFFAOYSA-N 3-Methylcytidine Natural products O=C1N(C)C(=N)C=CN1C1C(O)C(O)C(CO)O1 RDPUKVRQKWBSPK-UHFFFAOYSA-N 0.000 description 1
DXEJZRDJXRVUPN-XUTVFYLZSA-N 3-Methylpseudouridine Chemical compound O=C1N(C)C(=O)NC=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DXEJZRDJXRVUPN-XUTVFYLZSA-N 0.000 description 1
UTQUILVPBZEHTK-UHFFFAOYSA-N 3-Methyluridine Natural products O=C1N(C)C(=O)C=CN1C1C(O)C(O)C(CO)O1 UTQUILVPBZEHTK-UHFFFAOYSA-N 0.000 description 1
HOEIPINIBKBXTJ-IDTAVKCVSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6,7-trimethylimidazo[1,2-a]purin-9-one Chemical compound C1=NC=2C(=O)N3C(C)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HOEIPINIBKBXTJ-IDTAVKCVSA-N 0.000 description 1
HWVZAFVZKCCYAS-CLFAGFIQSA-N 3-[1,3-bis[[(Z)-octadec-9-enoyl]oxy]propan-2-ylamino]propanoic acid Chemical compound C(CCCCCCC\C=C/CCCCCCCC)(=O)OCC(COC(CCCCCCC\C=C/CCCCCCCC)=O)NCCC(=O)O HWVZAFVZKCCYAS-CLFAGFIQSA-N 0.000 description 1
AWAYFKRWHHEPNM-UHFFFAOYSA-N 3-[1,3-di(octadecanoyloxy)propan-2-ylamino]propanoic acid Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)OCC(COC(CCCCCCCCCCCCCCCCC)=O)NCCC(=O)O AWAYFKRWHHEPNM-UHFFFAOYSA-N 0.000 description 1
RIQHMABUWMQZJV-UHFFFAOYSA-N 3-[2-(didodecylamino)ethyl-dodecylamino]propan-1-ol Chemical compound CCCCCCCCCCCCN(CCCO)CCN(CCCCCCCCCCCC)CCCCCCCCCCCC RIQHMABUWMQZJV-UHFFFAOYSA-N 0.000 description 1
UDFFIGDHAYXXDS-HZJYTTRNSA-N 3-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxyethylamino]propanoic acid Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)OCCNCCC(=O)O UDFFIGDHAYXXDS-HZJYTTRNSA-N 0.000 description 1
DTKDRZRIPYITIW-KTKRTIGZSA-N 3-[2-[(Z)-octadec-9-enoyl]oxyethylamino]propanoic acid Chemical compound C(CCCCCCC\C=C/CCCCCCCC)(=O)OCCNCCC(=O)O DTKDRZRIPYITIW-KTKRTIGZSA-N 0.000 description 1
CDUMGCQRSJBAON-UHFFFAOYSA-N 3-[2-[di(nonyl)amino]ethyl-nonylamino]-1-[4-[3-[di(nonyl)amino]propyl]piperidin-1-yl]propan-1-one Chemical compound C(CCCCCCCC)N(CCN(CCC(=O)N1CCC(CC1)CCCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC)CCCCCCCCC CDUMGCQRSJBAON-UHFFFAOYSA-N 0.000 description 1
KKMJGOWNIFWYSL-UHFFFAOYSA-N 3-[2-[di(tetradecyl)amino]ethyl-dodecylamino]propan-1-ol Chemical compound C(CCCCCCCCCCCCC)N(CCN(CCCO)CCCCCCCCCCCC)CCCCCCCCCCCCCC KKMJGOWNIFWYSL-UHFFFAOYSA-N 0.000 description 1
AHVZCQRHQQHWJC-UHFFFAOYSA-N 3-[3-[1-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperidin-4-yl]propyl-nonylamino]propyl hexanoate Chemical compound C(CCCCC)(=O)OCCCN(CCCCCCCCC)CCCC1CCN(CC1)C(CCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)=O AHVZCQRHQQHWJC-UHFFFAOYSA-N 0.000 description 1
ANWHSALLHZAUQY-IUPFWZBJSA-N 3-[[1,3-bis[[(Z)-octadec-9-enoyl]oxy]-2-[[(Z)-octadec-9-enoyl]oxymethyl]propan-2-yl]amino]propanoic acid Chemical compound C(CCCCCCC\C=C/CCCCCCCC)(=O)OCC(COC(CCCCCCC\C=C/CCCCCCCC)=O)(COC(CCCCCCC\C=C/CCCCCCCC)=O)NCCC(=O)O ANWHSALLHZAUQY-IUPFWZBJSA-N 0.000 description 1
WXZKBSPCGCKIEV-UHFFFAOYSA-N 3-[[1,3-di(octadecanoyloxy)-2-(octadecanoyloxymethyl)propan-2-yl]amino]propanoic acid Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)OCC(COC(CCCCCCCCCCCCCCCCC)=O)(COC(CCCCCCCCCCCCCCCCC)=O)NCCC(=O)O WXZKBSPCGCKIEV-UHFFFAOYSA-N 0.000 description 1
BVZVICBYYOYVEP-MAZCIEHSSA-N 3-[bis[(9z,12z)-octadeca-9,12-dienyl]amino]propane-1,2-diol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCN(CC(O)CO)CCCCCCCC\C=C/C\C=C/CCCCC BVZVICBYYOYVEP-MAZCIEHSSA-N 0.000 description 1
KINYKGGRZOKATB-UHFFFAOYSA-N 3-[di(nonyl)amino]-1-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]propan-1-one Chemical compound CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CCC(=O)N1CCN(CC1)C(=O)CCN(CCCCCCCCC)CCCCCCCCC KINYKGGRZOKATB-UHFFFAOYSA-N 0.000 description 1
QMYGFTJCQFEDST-UHFFFAOYSA-N 3-methoxybutyl acetate Chemical group COC(C)CCOC(C)=O QMYGFTJCQFEDST-UHFFFAOYSA-N 0.000 description 1
RDPUKVRQKWBSPK-ZOQUXTDFSA-N 3-methylcytidine Chemical compound O=C1N(C)C(=N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RDPUKVRQKWBSPK-ZOQUXTDFSA-N 0.000 description 1
ZXLPWTGHXLFUTJ-UHFFFAOYSA-N 4-(didecylamino)butanal Chemical compound C(CCCCCCCCC)N(CCCC=O)CCCCCCCCCC ZXLPWTGHXLFUTJ-UHFFFAOYSA-N 0.000 description 1
IXUGVJKHVCCUDB-UHFFFAOYSA-N 4-(didodecylamino)butan-1-ol Chemical compound CCCCCCCCCCCCN(CCCCO)CCCCCCCCCCCC IXUGVJKHVCCUDB-UHFFFAOYSA-N 0.000 description 1
ZSIINYPBPQCZKU-BQNZPOLKSA-O 4-Methoxy-1-methylpseudoisocytidine Chemical compound C[N+](CC1[C@H]([C@H]2O)O[C@@H](CO)[C@@H]2O)=C(N)N=C1OC ZSIINYPBPQCZKU-BQNZPOLKSA-O 0.000 description 1
FGFVODMBKZRMMW-XUTVFYLZSA-N 4-Methoxy-2-thiopseudouridine Chemical compound COC1=C(C=NC(=S)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O FGFVODMBKZRMMW-XUTVFYLZSA-N 0.000 description 1
HOCJTJWYMOSXMU-XUTVFYLZSA-N 4-Methoxypseudouridine Chemical compound COC1=C(C=NC(=O)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O HOCJTJWYMOSXMU-XUTVFYLZSA-N 0.000 description 1
VTGBLFNEDHVUQA-XUTVFYLZSA-N 4-Thio-1-methyl-pseudouridine Chemical compound S=C1NC(=O)N(C)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 VTGBLFNEDHVUQA-XUTVFYLZSA-N 0.000 description 1
DMUQOPXCCOBPID-XUTVFYLZSA-N 4-Thio-1-methylpseudoisocytidine Chemical compound CN1C=C(C(=S)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O DMUQOPXCCOBPID-XUTVFYLZSA-N 0.000 description 1
ZLOIGESWDJYCTF-UHFFFAOYSA-N 4-Thiouridine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-UHFFFAOYSA-N 0.000 description 1
HTROZTWMNIUSTF-UHFFFAOYSA-N 4-[2-(didodecylamino)ethyl-dodecylamino]butan-1-ol Chemical compound C(CCCCCCCCCCC)N(CCN(CCCCO)CCCCCCCCCCCC)CCCCCCCCCCCC HTROZTWMNIUSTF-UHFFFAOYSA-N 0.000 description 1
OCMSXKMNYAHJMU-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidine-5-carbaldehyde Chemical compound C1=C(C=O)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OCMSXKMNYAHJMU-JXOAFFINSA-N 0.000 description 1
LQQGJDJXUSAEMZ-UAKXSSHOSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one Chemical compound C1=C(I)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LQQGJDJXUSAEMZ-UAKXSSHOSA-N 0.000 description 1
OZHIJZYBTCTDQC-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2-thione Chemical compound S=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OZHIJZYBTCTDQC-JXOAFFINSA-N 0.000 description 1
229960000549 4-dimethylaminophenol Drugs 0.000 description 1
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
LOICBOXHPCURMU-UHFFFAOYSA-N 4-methoxy-pseudoisocytidine Chemical compound COC1NC(N)=NC=C1C(C1O)OC(CO)C1O LOICBOXHPCURMU-UHFFFAOYSA-N 0.000 description 1
SJVVKUMXGIKAAI-UHFFFAOYSA-N 4-thio-pseudoisocytidine Chemical compound NC(N1)=NC=C(C(C2O)OC(CO)C2O)C1=S SJVVKUMXGIKAAI-UHFFFAOYSA-N 0.000 description 1
ZLOIGESWDJYCTF-XVFCMESISA-N 4-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-XVFCMESISA-N 0.000 description 1
FAWQJBLSWXIJLA-VPCXQMTMSA-N 5-(carboxymethyl)uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CC(O)=O)=C1 FAWQJBLSWXIJLA-VPCXQMTMSA-N 0.000 description 1
YWWXDSGIFSZSFB-UHFFFAOYSA-N 5-(didecylamino)pentanal Chemical compound C(CCCCCCCCC)N(CCCCC=O)CCCCCCCCCC YWWXDSGIFSZSFB-UHFFFAOYSA-N 0.000 description 1
NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 description 1
NFEXJLMYXXIWPI-JXOAFFINSA-N 5-Hydroxymethylcytidine Chemical compound C1=C(CO)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NFEXJLMYXXIWPI-JXOAFFINSA-N 0.000 description 1
ZAYHVCMSTBRABG-UHFFFAOYSA-N 5-Methylcytidine Natural products O=C1N=C(N)C(C)=CN1C1C(O)C(O)C(CO)O1 ZAYHVCMSTBRABG-UHFFFAOYSA-N 0.000 description 1
ZYEWPVTXYBLWRT-UHFFFAOYSA-N 5-Uridinacetamid Natural products O=C1NC(=O)C(CC(=O)N)=CN1C1C(O)C(O)C(CO)O1 ZYEWPVTXYBLWRT-UHFFFAOYSA-N 0.000 description 1
ITGWEVGJUSMCEA-KYXWUPHJSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)N(C#CC)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ITGWEVGJUSMCEA-KYXWUPHJSA-N 0.000 description 1
DDHOXEOVAJVODV-GBNDHIKLSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=S)NC1=O DDHOXEOVAJVODV-GBNDHIKLSA-N 0.000 description 1
BNAWMJKJLNJZFU-GBNDHIKLSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidene-1h-pyrimidin-2-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=S BNAWMJKJLNJZFU-GBNDHIKLSA-N 0.000 description 1
OZQDLJNDRVBCST-SHUUEZRQSA-N 5-amino-2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazin-3-one Chemical compound O=C1N=C(N)C=NN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OZQDLJNDRVBCST-SHUUEZRQSA-N 0.000 description 1
XUNBIDXYAUXNKD-DBRKOABJSA-N 5-aza-2-thio-zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)N=CN=C1 XUNBIDXYAUXNKD-DBRKOABJSA-N 0.000 description 1
OSLBPVOJTCDNEF-DBRKOABJSA-N 5-aza-zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=CN=C1 OSLBPVOJTCDNEF-DBRKOABJSA-N 0.000 description 1
NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
ZYEWPVTXYBLWRT-VPCXQMTMSA-N 5-carbamoylmethyluridine Chemical compound O=C1NC(=O)C(CC(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZYEWPVTXYBLWRT-VPCXQMTMSA-N 0.000 description 1
VKLFQTYNHLDMDP-PNHWDRBUSA-N 5-carboxymethylaminomethyl-2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C(CNCC(O)=O)=C1 VKLFQTYNHLDMDP-PNHWDRBUSA-N 0.000 description 1
QJRZJUYDULYQPX-UHFFFAOYSA-N 5-heptyldodecanoic acid Chemical compound CCCCCCCC(CCCC(O)=O)CCCCCCC QJRZJUYDULYQPX-UHFFFAOYSA-N 0.000 description 1
ZXIATBNUWJBBGT-JXOAFFINSA-N 5-methoxyuridine Chemical compound O=C1NC(=O)C(OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZXIATBNUWJBBGT-JXOAFFINSA-N 0.000 description 1
KBDWGFZSICOZSJ-UHFFFAOYSA-N 5-methyl-2,3-dihydro-1H-pyrimidin-4-one Chemical compound N1CNC=C(C1=O)C KBDWGFZSICOZSJ-UHFFFAOYSA-N 0.000 description 1
ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
SNNBPMAXGYBMHM-JXOAFFINSA-N 5-methyl-2-thiouridine Chemical compound S=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 SNNBPMAXGYBMHM-JXOAFFINSA-N 0.000 description 1
RPQQZHJQUBDHHG-FNCVBFRFSA-N 5-methyl-zebularine Chemical compound C1=C(C)C=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RPQQZHJQUBDHHG-FNCVBFRFSA-N 0.000 description 1
ZXQHKBUIXRFZBV-FDDDBJFASA-N 5-methylaminomethyluridine Chemical compound O=C1NC(=O)C(CNC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZXQHKBUIXRFZBV-FDDDBJFASA-N 0.000 description 1
ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 description 1
UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
USVMJSALORZVDV-UHFFFAOYSA-N 6-(gamma,gamma-dimethylallylamino)purine riboside Natural products C1=NC=2C(NCC=C(C)C)=NC=NC=2N1C1OC(CO)C(O)C1O USVMJSALORZVDV-UHFFFAOYSA-N 0.000 description 1
ZKBQDFAWXLTYKS-UHFFFAOYSA-N 6-Chloro-1H-purine Chemical compound ClC1=NC=NC2=C1NC=N2 ZKBQDFAWXLTYKS-UHFFFAOYSA-N 0.000 description 1
OZTOEARQSSIFOG-MWKIOEHESA-N 6-Thio-7-deaza-8-azaguanosine Chemical compound Nc1nc(=S)c2cnn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1 OZTOEARQSSIFOG-MWKIOEHESA-N 0.000 description 1
KXBCLNRMQPRVTP-UHFFFAOYSA-N 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one Chemical compound O=C1NC(N)=CC2=C1N=CN2 KXBCLNRMQPRVTP-UHFFFAOYSA-N 0.000 description 1
DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
WYXSYVWAUAUWLD-SHUUEZRQSA-N 6-azauridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=N1 WYXSYVWAUAUWLD-SHUUEZRQSA-N 0.000 description 1
RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 description 1
AFWWNHLDHNSVSD-UHFFFAOYSA-N 6-methyl-7h-purin-2-amine Chemical compound CC1=NC(N)=NC2=C1NC=N2 AFWWNHLDHNSVSD-UHFFFAOYSA-N 0.000 description 1
CBNRZZNSRJQZNT-IOSLPCCCSA-O 6-thio-7-deaza-guanosine Chemical compound CC1=C[NH+]([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)C(NC(N)=N2)=C1C2=S CBNRZZNSRJQZNT-IOSLPCCCSA-O 0.000 description 1
RFHIWBUKNJIBSE-KQYNXXCUSA-O 6-thio-7-methyl-guanosine Chemical compound C1=2NC(N)=NC(=S)C=2N(C)C=[N+]1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RFHIWBUKNJIBSE-KQYNXXCUSA-O 0.000 description 1
MJJUWOIBPREHRU-MWKIOEHESA-N 7-Deaza-8-azaguanosine Chemical compound NC=1NC(C2=C(N=1)N(N=C2)[C@H]1[C@H](O)[C@H](O)[C@H](O1)CO)=O MJJUWOIBPREHRU-MWKIOEHESA-N 0.000 description 1
FMKSMYDYKXQYRV-UHFFFAOYSA-N 7-cyano-7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1C(C#N)=CN2 FMKSMYDYKXQYRV-UHFFFAOYSA-N 0.000 description 1
ISSMDAFGDCTNDV-UHFFFAOYSA-N 7-deaza-2,6-diaminopurine Chemical compound NC1=NC(N)=C2NC=CC2=N1 ISSMDAFGDCTNDV-UHFFFAOYSA-N 0.000 description 1
YVVMIGRXQRPSIY-UHFFFAOYSA-N 7-deaza-2-aminopurine Chemical compound N1C(N)=NC=C2C=CN=C21 YVVMIGRXQRPSIY-UHFFFAOYSA-N 0.000 description 1
ZTAWTRPFJHKMRU-UHFFFAOYSA-N 7-deaza-8-aza-2,6-diaminopurine Chemical compound NC1=NC(N)=C2NN=CC2=N1 ZTAWTRPFJHKMRU-UHFFFAOYSA-N 0.000 description 1
SMXRCJBCWRHDJE-UHFFFAOYSA-N 7-deaza-8-aza-2-aminopurine Chemical compound NC1=NC=C2C=NNC2=N1 SMXRCJBCWRHDJE-UHFFFAOYSA-N 0.000 description 1
LHCPRYRLDOSKHK-UHFFFAOYSA-N 7-deaza-8-aza-adenine Chemical compound NC1=NC=NC2=C1C=NN2 LHCPRYRLDOSKHK-UHFFFAOYSA-N 0.000 description 1
LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
ZVDWKWBEIOEXQK-UHFFFAOYSA-N 7-hexyltridecanoic acid Chemical compound CCCCCCC(CCCCCC)CCCCCC(O)=O ZVDWKWBEIOEXQK-UHFFFAOYSA-N 0.000 description 1
OGHAROSJZRTIOK-KQYNXXCUSA-O 7-methylguanosine Chemical compound C1=2N=C(N)NC(=O)C=2[N+](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-O 0.000 description 1
VJNXUFOTKNTNPG-IOSLPCCCSA-O 7-methylinosine Chemical compound C1=2NC=NC(=O)C=2N(C)C=[N+]1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VJNXUFOTKNTNPG-IOSLPCCCSA-O 0.000 description 1
HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical compound NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 1
229960005508 8-azaguanine Drugs 0.000 description 1
ADPMAYFIIFNDMT-KQYNXXCUSA-N 9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(methylamino)-3h-purine-6-thione Chemical compound C1=NC=2C(=S)NC(NC)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ADPMAYFIIFNDMT-KQYNXXCUSA-N 0.000 description 1
OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
JGAJDHRXKJAGLF-UHFFFAOYSA-N 9-pentyltetradecanoic acid Chemical compound C(CCCC)C(CCCCCCCC(=O)O)CCCCC JGAJDHRXKJAGLF-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
208000010470 Ageusia Diseases 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
206010002653 Anosmia Diseases 0.000 description 1
108010085443 Anserine Proteins 0.000 description 1
PEMQXWCOMFJRLS-UHFFFAOYSA-N Archaeosine Natural products C1=2NC(N)=NC(=O)C=2C(C(=N)N)=CN1C1OC(CO)C(O)C1O PEMQXWCOMFJRLS-UHFFFAOYSA-N 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
BZDJCEWYMGXKCC-UHFFFAOYSA-N C(CCCCCCCC)(=O)OCCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC Chemical compound C(CCCCCCCC)(=O)OCCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC BZDJCEWYMGXKCC-UHFFFAOYSA-N 0.000 description 1
VIXATDRZWYRSBW-UHFFFAOYSA-N C(CCCCCCCCCCCCC)(=O)OCCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC Chemical compound C(CCCCCCCCCCCCC)(=O)OCCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC VIXATDRZWYRSBW-UHFFFAOYSA-N 0.000 description 1
QSXYZCXVYQFQAV-UHFFFAOYSA-N C(CCCCCCCCCCCCC)C(N(C)C)CCCCCCCCCCCCCC Chemical compound C(CCCCCCCCCCCCC)C(N(C)C)CCCCCCCCCCCCCC QSXYZCXVYQFQAV-UHFFFAOYSA-N 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
IXTUSQSJHKRGGL-UHFFFAOYSA-N CCCCCCCC(OCCCCCCC(CC(CC(CCCCCCOC(CCCCCCC)=O)C(O)=O)COC(C1(C)CN(C)CC1)=O)C(O)=O)=O Chemical compound CCCCCCCC(OCCCCCCC(CC(CC(CCCCCCOC(CCCCCCC)=O)C(O)=O)COC(C1(C)CN(C)CC1)=O)C(O)=O)=O IXTUSQSJHKRGGL-UHFFFAOYSA-N 0.000 description 1
ZPGOFQMJAGSCMT-VYEFPUSRSA-N CCCCCCCCC(CCCCCCCC)CC(CCCCC(CCCCCC/C=C\C/C=C\CCCCC)C(=O)O)OC(=O)OCCCN(C)C Chemical compound CCCCCCCCC(CCCCCCCC)CC(CCCCC(CCCCCC/C=C\C/C=C\CCCCC)C(=O)O)OC(=O)OCCCN(C)C ZPGOFQMJAGSCMT-VYEFPUSRSA-N 0.000 description 1
GPHNNLAMKGYYIX-UHFFFAOYSA-N CCCCCCCCCC(CCCCCCC)(CC(CC(CCCCCCC)(CCCCCCCCC)C(O)=O)COC(OCCCN(C)C)=O)C(O)=O Chemical compound CCCCCCCCCC(CCCCCCC)(CC(CC(CCCCCCC)(CCCCCCCCC)C(O)=O)COC(OCCCN(C)C)=O)C(O)=O GPHNNLAMKGYYIX-UHFFFAOYSA-N 0.000 description 1
YOOJWLXBZWGGFW-UHFFFAOYSA-N CCCCCCCCCCCCC(CCC(OC(CCCCCCCCCCC(O)=O)CCCCCCCCCCC(O)=O)=O)OC(OCCCN(C)CC)=O Chemical compound CCCCCCCCCCCCC(CCC(OC(CCCCCCCCCCC(O)=O)CCCCCCCCCCC(O)=O)=O)OC(OCCCN(C)CC)=O YOOJWLXBZWGGFW-UHFFFAOYSA-N 0.000 description 1
IJIWTIOFWZXACT-VYEFPUSRSA-N CCCCCCCCOC(CCC(=O)OCC(CC(CCCCCC/C=C\C/C=C\CCCCC)C(=O)O)COC(=O)OCC1CCCN(C1)CC)OCCCCCCCC Chemical compound CCCCCCCCOC(CCC(=O)OCC(CC(CCCCCC/C=C\C/C=C\CCCCC)C(=O)O)COC(=O)OCC1CCCN(C1)CC)OCCCCCCCC IJIWTIOFWZXACT-VYEFPUSRSA-N 0.000 description 1
BLIPNMXZHIPUOI-OIRSPXBMSA-N CCN(CC)CCC(OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)=O Chemical compound CCN(CC)CCC(OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)=O BLIPNMXZHIPUOI-OIRSPXBMSA-N 0.000 description 1
PCBZRNYXXCIELG-WYFCWLEVSA-N COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 Chemical compound COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 PCBZRNYXXCIELG-WYFCWLEVSA-N 0.000 description 1
229940022962 COVID-19 vaccine Drugs 0.000 description 1
101100236724 Caenorhabditis elegans mcm-5 gene Proteins 0.000 description 1
241000204432 Candidatus Sodalis pierantonius str. SOPE Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
108010087806 Carnosine Proteins 0.000 description 1
108091005462 Cation channels Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
108700002099 Coronavirus Nucleocapsid Proteins Proteins 0.000 description 1
206010011224 Cough Diseases 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
108010041986 DNA Vaccines Proteins 0.000 description 1
230000009946 DNA mutation Effects 0.000 description 1
102000004214 DNA polymerase A Human genes 0.000 description 1
108090000725 DNA polymerase A Proteins 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
229940021995 DNA vaccine Drugs 0.000 description 1
XULFJDKZVHTRLG-JDVCJPALSA-N DOSPA trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F.CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)CCNC(=O)C(CCCNCCCN)NCCCN)OCCCCCCCC\C=C/CCCCCCCC XULFJDKZVHTRLG-JDVCJPALSA-N 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
YKWUPFSEFXSGRT-JWMKEVCDSA-N Dihydropseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1C(=O)NC(=O)NC1 YKWUPFSEFXSGRT-JWMKEVCDSA-N 0.000 description 1
208000000059 Dyspnea Diseases 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
101710091918 Eukaryotic translation initiation factor 4E Proteins 0.000 description 1
102100027304 Eukaryotic translation initiation factor 4E Human genes 0.000 description 1
101710126428 Eukaryotic translation initiation factor 4E-2 Proteins 0.000 description 1
101710126416 Eukaryotic translation initiation factor 4E-3 Proteins 0.000 description 1
101710126432 Eukaryotic translation initiation factor 4E1 Proteins 0.000 description 1
101710133325 Eukaryotic translation initiation factor NCBP Proteins 0.000 description 1
101710190212 Eukaryotic translation initiation factor isoform 4E Proteins 0.000 description 1
101710124729 Eukaryotic translation initiation factor isoform 4E-2 Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000001974 Hyaluronidases Human genes 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
108010042653 IgA receptor Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
241000282339 Mustela Species 0.000 description 1
208000000112 Myalgia Diseases 0.000 description 1
RSPURTUNRHNVGF-IOSLPCCCSA-N N(2),N(2)-dimethylguanosine Chemical compound C1=NC=2C(=O)NC(N(C)C)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RSPURTUNRHNVGF-IOSLPCCCSA-N 0.000 description 1
SLEHROROQDYRAW-KQYNXXCUSA-N N(2)-methylguanosine Chemical compound C1=NC=2C(=O)NC(NC)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O SLEHROROQDYRAW-KQYNXXCUSA-N 0.000 description 1
NIDVTARKFBZMOT-PEBGCTIMSA-N N(4)-acetylcytidine Chemical compound O=C1N=C(NC(=O)C)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NIDVTARKFBZMOT-PEBGCTIMSA-N 0.000 description 1
WVGPGNPCZPYCLK-WOUKDFQISA-N N(6),N(6)-dimethyladenosine Chemical compound C1=NC=2C(N(C)C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WVGPGNPCZPYCLK-WOUKDFQISA-N 0.000 description 1
USVMJSALORZVDV-SDBHATRESA-N N(6)-(Delta(2)-isopentenyl)adenosine Chemical compound C1=NC=2C(NCC=C(C)C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O USVMJSALORZVDV-SDBHATRESA-N 0.000 description 1
WVGPGNPCZPYCLK-UHFFFAOYSA-N N-Dimethyladenosine Natural products C1=NC=2C(N(C)C)=NC=NC=2N1C1OC(CO)C(O)C1O WVGPGNPCZPYCLK-UHFFFAOYSA-N 0.000 description 1
UNUYMBPXEFMLNW-DWVDDHQFSA-N N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine Chemical compound C1=NC=2C(NC(=O)N[C@@H]([C@H](O)C)C(O)=O)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UNUYMBPXEFMLNW-DWVDDHQFSA-N 0.000 description 1
SLLVJTURCPWLTP-UHFFFAOYSA-N N-[9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]acetamide Chemical compound C1=NC=2C(NC(=O)C)=NC=NC=2N1C1OC(CO)C(O)C1O SLLVJTURCPWLTP-UHFFFAOYSA-N 0.000 description 1
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
XEIMJDMWIZORAY-UHFFFAOYSA-N N-dodecyl-N-(2-piperazin-1-ylethyl)dodecan-1-amine Chemical compound C(CCCCCCCCCCC)N(CCN1CCNCC1)CCCCCCCCCCCC XEIMJDMWIZORAY-UHFFFAOYSA-N 0.000 description 1
RIUSOEYVJCYOOF-UHFFFAOYSA-N N-dodecyl-N-[2-[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]ethyl]dodecan-1-amine Chemical compound C(CCCCCCCCCCC)N(CCCCCCCCCCCC)CCN1CCN(CC1)CC1=CC=C(C=C1)OC RIUSOEYVJCYOOF-UHFFFAOYSA-N 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
LZCNWAXLJWBRJE-ZOQUXTDFSA-N N4-Methylcytidine Chemical compound O=C1N=C(NC)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LZCNWAXLJWBRJE-ZOQUXTDFSA-N 0.000 description 1
GOSWTRUMMSCNCW-UHFFFAOYSA-N N6-(cis-hydroxyisopentenyl)adenosine Chemical compound C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1OC(CO)C(O)C1O GOSWTRUMMSCNCW-UHFFFAOYSA-N 0.000 description 1
VQAYFKKCNSOZKM-UHFFFAOYSA-N NSC 29409 Natural products C1=NC=2C(NC)=NC=NC=2N1C1OC(CO)C(O)C1O VQAYFKKCNSOZKM-UHFFFAOYSA-N 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
VZQXUWKZDSEQRR-UHFFFAOYSA-N Nucleosid Natural products C12=NC(SC)=NC(NCC=C(C)C)=C2N=CN1C1OC(CO)C(O)C1O VZQXUWKZDSEQRR-UHFFFAOYSA-N 0.000 description 1
JXNORPPTKDEAIZ-QOCRDCMYSA-N O-4''-alpha-D-mannosylqueuosine Chemical compound NC(N1)=NC(N([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)C=C2CN[C@H]([C@H]3O)C=C[C@@H]3O[C@H]([C@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)=C2C1=O JXNORPPTKDEAIZ-QOCRDCMYSA-N 0.000 description 1
SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 1
108700022034 Opsonin Proteins Proteins 0.000 description 1
206010068319 Oropharyngeal pain Diseases 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
PAOSTKHFCVLKCZ-SAKSZPOZSA-N P(=O)(O)(O)OC[C@@H]1[C@H]([C@]([C@@H](O1)N1C=NC=2C(N)=NC=NC1=2)(O)C1[C@H](O)[C@H](O)[C@H](O1)CO)O Chemical compound P(=O)(O)(O)OC[C@@H]1[C@H]([C@]([C@@H](O1)N1C=NC=2C(N)=NC=NC1=2)(O)C1[C@H](O)[C@H](O)[C@H](O1)CO)O PAOSTKHFCVLKCZ-SAKSZPOZSA-N 0.000 description 1
WIHSZOXPODIZSW-KJIWEYRQSA-N PE(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC WIHSZOXPODIZSW-KJIWEYRQSA-N 0.000 description 1
239000008118 PEG 6000 Substances 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000002508 Peptide Elongation Factors Human genes 0.000 description 1
108010068204 Peptide Elongation Factors Proteins 0.000 description 1
208000005228 Pericardial Effusion Diseases 0.000 description 1
201000007100 Pharyngitis Diseases 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
102000015623 Polynucleotide Adenylyltransferase Human genes 0.000 description 1
108010024055 Polynucleotide adenylyltransferase Proteins 0.000 description 1
241000210053 Potentilla elegans Species 0.000 description 1
241000288906 Primates Species 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
102000007327 Protamines Human genes 0.000 description 1
108010007568 Protamines Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101710194807 Protective antigen Proteins 0.000 description 1
101800001255 Putative 2'-O-methyl transferase Proteins 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
230000004570 RNA-binding Effects 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
241000700159 Rattus Species 0.000 description 1
208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
208000036071 Rhinorrhea Diseases 0.000 description 1
206010039101 Rhinorrhoea Diseases 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000315672 SARS coronavirus Species 0.000 description 1
108091006197 SARS-CoV-2 Nucleocapsid Protein Proteins 0.000 description 1
208000037847 SARS-CoV-2-infection Diseases 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
101001024637 Severe acute respiratory syndrome coronavirus 2 Nucleoprotein Proteins 0.000 description 1
101000970479 Severe acute respiratory syndrome coronavirus 2 ORF8 protein Proteins 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
102220599612 Spindlin-1_A701V_mutation Human genes 0.000 description 1
102220599632 Spindlin-1_F888L_mutation Human genes 0.000 description 1
102220590696 Spindlin-1_G142D_mutation Human genes 0.000 description 1
102220599629 Spindlin-1_Q1071H_mutation Human genes 0.000 description 1
102220590684 Spindlin-1_T95I_mutation Human genes 0.000 description 1
241000282887 Suidae Species 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
241000589500 Thermus aquaticus Species 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
108091046915 Threose nucleic acid Proteins 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
101710198378 Uncharacterized 10.8 kDa protein in cox-rep intergenic region Proteins 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
230000010530 Virus Neutralization Effects 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
JCZSFCLRSONYLH-UHFFFAOYSA-N Wyosine Natural products N=1C(C)=CN(C(C=2N=C3)=O)C=1N(C)C=2N3C1OC(CO)C(O)C1O JCZSFCLRSONYLH-UHFFFAOYSA-N 0.000 description 1
241001441550 Zeiformes Species 0.000 description 1
NJFCSWSRXWCWHV-USYZEHPZSA-N [(2R)-2,3-bis(octadec-1-enoxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCCC=COC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC=CCCCCCCCCCCCCCCCC NJFCSWSRXWCWHV-USYZEHPZSA-N 0.000 description 1
SUTHKQVOHCMCCF-QZNUWAOFSA-N [(2r)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-docosa-2,4,6,8,10,12-hexaenoyloxypropyl] docosa-2,4,6,8,10,12-hexaenoate Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)C=CC=CC=CC=CC=CC=CCCCCCCCCC SUTHKQVOHCMCCF-QZNUWAOFSA-N 0.000 description 1
LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
TVGUROHJABCRTB-MHJQXXNXSA-N [(2r,3s,4r,5s)-5-[(2r,3r,4r,5r)-2-(2-amino-6-oxo-3h-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound O([C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C=NC=2C(=O)N=C(NC=21)N)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O TVGUROHJABCRTB-MHJQXXNXSA-N 0.000 description 1
ISXSJGHXHUZXNF-LXZPIJOJSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate;hydrochloride Chemical compound Cl.C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 ISXSJGHXHUZXNF-LXZPIJOJSA-N 0.000 description 1
TTWXVHUYMARJHI-KWXKLSQISA-N [(6Z,9Z,29Z,32Z)-20-[(dimethylamino)methyl]octatriaconta-6,9,29,32-tetraen-19-yl] carbamate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(CN(C)C)C(OC(N)=O)CCCCCCCC\C=C/C\C=C/CCCCC TTWXVHUYMARJHI-KWXKLSQISA-N 0.000 description 1
YWBULOYFCXZCGF-UHFFFAOYSA-N [1,3]thiazolo[4,5-d]pyrimidine Chemical class C1=NC=C2SC=NC2=N1 YWBULOYFCXZCGF-UHFFFAOYSA-N 0.000 description 1
CHTXXFZHKGGQGX-UHFFFAOYSA-N [2-[3-(diethylamino)propoxycarbonyloxymethyl]-3-(4,4-dioctoxybutanoyloxy)propyl] (9Z,12Z)-octadeca-9,12-dienoate Chemical compound C(CCCCCCCC=C/CC=C/CCCCC)(=O)OCC(COC(CCC(OCCCCCCCC)OCCCCCCCC)=O)COC(=O)OCCCN(CC)CC CHTXXFZHKGGQGX-UHFFFAOYSA-N 0.000 description 1
SBCVJZHHHVYKNM-UHFFFAOYSA-M [2-[bis(2-tetradecanoyloxyethyl)amino]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC(=O)OCCN(C(=O)C[N+](C)(C)CCO)CCOC(=O)CCCCCCCCCCCCC SBCVJZHHHVYKNM-UHFFFAOYSA-M 0.000 description 1
HCAJCMUKLZSPFT-KWXKLSQISA-N [3-(dimethylamino)-2-[(9z,12z)-octadeca-9,12-dienoyl]oxypropyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC HCAJCMUKLZSPFT-KWXKLSQISA-N 0.000 description 1
NYDLOCKCVISJKK-WRBBJXAJSA-N [3-(dimethylamino)-2-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC NYDLOCKCVISJKK-WRBBJXAJSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
ZFFZMGJMZGAGMF-SXAUZNKPSA-N [7-[4-(dipropylamino)butyl]-7-hydroxy-13-[(Z)-octadec-9-enoyl]oxytridecyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCC(O)(CCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC)CCCCN(CCC)CCC ZFFZMGJMZGAGMF-SXAUZNKPSA-N 0.000 description 1
BWQWDZDWUKXQAF-UHFFFAOYSA-N [Cl-].C(CCCCCCCCCCCCCCCCC)[NH+](CC(O)O)CCCCCCCCCCCCCCCCCC Chemical compound [Cl-].C(CCCCCCCCCCCCCCCCC)[NH+](CC(O)O)CCCCCCCCCCCCCCCCCC BWQWDZDWUKXQAF-UHFFFAOYSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
150000003838 adenosines Chemical class 0.000 description 1
201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
235000019666 ageusia Nutrition 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
HUMHYXGDUOGHTG-HEZXSMHISA-N alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-D-Galp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)OC1O HUMHYXGDUOGHTG-HEZXSMHISA-N 0.000 description 1
125000002714 alpha-linolenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])[H] 0.000 description 1
125000002431 aminoalkoxy group Chemical group 0.000 description 1
125000004103 aminoalkyl group Chemical group 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
210000001742 aqueous humor Anatomy 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
PEMQXWCOMFJRLS-RPKMEZRRSA-N archaeosine Chemical compound C1=2NC(N)=NC(=O)C=2C(C(=N)N)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O PEMQXWCOMFJRLS-RPKMEZRRSA-N 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
210000003567 ascitic fluid Anatomy 0.000 description 1
229960002756 azacitidine Drugs 0.000 description 1
108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
QVZZPLDJERFENQ-NKTUOASPSA-N bassianolide Chemical compound CC(C)C[C@@H]1N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C(C)C)OC1=O QVZZPLDJERFENQ-NKTUOASPSA-N 0.000 description 1
230000008901 benefit Effects 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000000090 biomarker Substances 0.000 description 1
230000006287 biotinylation Effects 0.000 description 1
238000007413 biotinylation Methods 0.000 description 1
210000004952 blastocoel Anatomy 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
208000027499 body ache Diseases 0.000 description 1
230000037396 body weight Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
101150013240 bpt gene Proteins 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
150000003842 bromide salts Chemical class 0.000 description 1
239000000872 buffer Substances 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 1
SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
DFFDSQBEGQFJJU-UHFFFAOYSA-M butyl carbonate Chemical compound CCCCOC([O-])=O DFFDSQBEGQFJJU-UHFFFAOYSA-M 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
QEEYIPNXVWZNFN-UHFFFAOYSA-N butyl pentanoate Chemical compound [CH2]CCCC(=O)OCCCC QEEYIPNXVWZNFN-UHFFFAOYSA-N 0.000 description 1
MPBRYMWMMKKRGC-UHFFFAOYSA-M carbocyanin DBTC Chemical compound [Br-].C1=CC=CC2=C([N+](=C(C=C(C)C=C3N(C4=C5C=CC=CC5=CC=C4S3)CC)S3)CC)C3=CC=C21 MPBRYMWMMKKRGC-UHFFFAOYSA-M 0.000 description 1
229940044199 carnosine Drugs 0.000 description 1
CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
229920006317 cationic polymer Polymers 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
229930183167 cerebroside Natural products 0.000 description 1
RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
210000002939 cerumen Anatomy 0.000 description 1
210000003756 cervix mucus Anatomy 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
210000001268 chyle Anatomy 0.000 description 1
210000004913 chyme Anatomy 0.000 description 1
230000004087 circulation Effects 0.000 description 1
238000003501 co-culture Methods 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
208000027744 congestion Diseases 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000011258 core-shell material Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
125000000000 cycloalkoxy group Chemical group 0.000 description 1
RHJVIGLEIFVHIJ-UHFFFAOYSA-N cyclohexanecarboxamide Chemical compound NC(=O)C1[CH]CCCC1 RHJVIGLEIFVHIJ-UHFFFAOYSA-N 0.000 description 1
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
210000002726 cyst fluid Anatomy 0.000 description 1
229960000684 cytarabine Drugs 0.000 description 1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
230000009849 deactivation Effects 0.000 description 1
MQANMCFSNPBYCQ-UHFFFAOYSA-N decan-2-amine Chemical compound CCCCCCCCC(C)N MQANMCFSNPBYCQ-UHFFFAOYSA-N 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
229940124447 delivery agent Drugs 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000011026 diafiltration Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
PIZLBWGMERQCOC-UHFFFAOYSA-N dibenzyl carbonate Chemical compound C=1C=CC=CC=1COC(=O)OCC1=CC=CC=C1 PIZLBWGMERQCOC-UHFFFAOYSA-N 0.000 description 1
UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
UAKOZKUVZRMOFN-JDVCJPALSA-M dimethyl-bis[(z)-octadec-9-enyl]azanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CCCCCCCC\C=C/CCCCCCCC UAKOZKUVZRMOFN-JDVCJPALSA-M 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
238000009826 distribution Methods 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 1
RRCFLRBBBFZLSB-XIFYLAFSSA-N epoxyqueuosine Chemical compound C1=C(CN[C@@H]2[C@H]([C@@H](O)[C@@H]3O[C@@H]32)O)C=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RRCFLRBBBFZLSB-XIFYLAFSSA-N 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
PNZDZRMOBIIQTC-UHFFFAOYSA-N ethanamine;hydron;bromide Chemical compound Br.CCN PNZDZRMOBIIQTC-UHFFFAOYSA-N 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
WGUAXUBTLISAGY-OWBHPGMISA-N ethyl (Z)-17-[(dimethylamino)methyl]hexacos-7-enoate Chemical compound CCCCCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCC(=O)OCC WGUAXUBTLISAGY-OWBHPGMISA-N 0.000 description 1
GZQUHGZKVWSEMF-OWBHPGMISA-N ethyl (Z)-17-[2-(dimethylamino)ethyl]hexacos-7-enoate Chemical compound CCCCCCCCCC(CCN(C)C)CCCCCCCC\C=C/CCCCCC(=O)OCC GZQUHGZKVWSEMF-OWBHPGMISA-N 0.000 description 1
VIUHALOKCMDXBN-MNDPQUGUSA-N ethyl (z)-17-(dimethylamino)hexacos-5-enoate Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCC\C=C/CCCC(=O)OCC VIUHALOKCMDXBN-MNDPQUGUSA-N 0.000 description 1
NRRXQJMSOQZIJL-OWBHPGMISA-N ethyl (z)-17-(dimethylamino)hexacos-7-enoate Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCC\C=C/CCCCCC(=O)OCC NRRXQJMSOQZIJL-OWBHPGMISA-N 0.000 description 1
VDINUCAHEZCFTK-KHPPLWFESA-N ethyl (z)-17-(dimethylamino)hexacos-9-enoate Chemical compound CCCCCCCCCC(N(C)C)CCCCCC\C=C/CCCCCCCC(=O)OCC VDINUCAHEZCFTK-KHPPLWFESA-N 0.000 description 1
VQXCXDFNPIFZNB-OWBHPGMISA-N ethyl (z)-17-(dimethylamino)pentacos-7-enoate Chemical compound CCCCCCCCC(N(C)C)CCCCCCCC\C=C/CCCCCC(=O)OCC VQXCXDFNPIFZNB-OWBHPGMISA-N 0.000 description 1
ZWMMJINSTQTJJH-QBFSEMIESA-N ethyl (z)-17-(dimethylamino)tetracos-7-enoate Chemical compound CCCCCCCC(N(C)C)CCCCCCCC\C=C/CCCCCC(=O)OCC ZWMMJINSTQTJJH-QBFSEMIESA-N 0.000 description 1
RCOATPPXJOOHIG-QBFSEMIESA-N ethyl (z)-17-(dimethylamino)tricos-7-enoate Chemical compound CCCCCCC(N(C)C)CCCCCCCC\C=C/CCCCCC(=O)OCC RCOATPPXJOOHIG-QBFSEMIESA-N 0.000 description 1
KJFFRTWIDPSTBH-MNDPQUGUSA-N ethyl (z)-17-[(dimethylamino)methyl]hexacos-5-enoate Chemical compound CCCCCCCCCC(CN(C)C)CCCCCCCCCC\C=C/CCCC(=O)OCC KJFFRTWIDPSTBH-MNDPQUGUSA-N 0.000 description 1
UYSWYDJLIZQPGJ-QBFSEMIESA-N ethyl (z)-17-[(dimethylamino)methyl]tricos-7-enoate Chemical compound CCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCC(=O)OCC UYSWYDJLIZQPGJ-QBFSEMIESA-N 0.000 description 1
HAGRQIJBZPBOMQ-LUAWRHEFSA-N ethyl (z)-19-(dimethylamino)pentacos-9-enoate Chemical compound CCCCCCC(N(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OCC HAGRQIJBZPBOMQ-LUAWRHEFSA-N 0.000 description 1
JKTIFAVBLFXXTK-BENRWUELSA-N ethyl (z)-19-[(dimethylamino)methyl]heptacos-9-enoate Chemical compound CCCCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OCC JKTIFAVBLFXXTK-BENRWUELSA-N 0.000 description 1
GHYIPMWGXGDPNU-LUAWRHEFSA-N ethyl (z)-19-[(dimethylamino)methyl]hexacos-9-enoate Chemical compound CCCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OCC GHYIPMWGXGDPNU-LUAWRHEFSA-N 0.000 description 1
MBQJXISRXMESAG-BENRWUELSA-N ethyl (z)-19-[(dimethylamino)methyl]octacos-9-enoate Chemical compound CCCCCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OCC MBQJXISRXMESAG-BENRWUELSA-N 0.000 description 1
STONITNOCIUBEF-LUAWRHEFSA-N ethyl (z)-19-[(dimethylamino)methyl]pentacos-9-enoate Chemical compound CCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OCC STONITNOCIUBEF-LUAWRHEFSA-N 0.000 description 1
YFUPDIHIUUMEDY-OWBHPGMISA-N ethyl (z)-21-(dimethylamino)nonacos-9-enoate Chemical compound CCCCCCCCC(N(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OCC YFUPDIHIUUMEDY-OWBHPGMISA-N 0.000 description 1
AOSJUJLNWRQIPY-QBFSEMIESA-N ethyl (z)-21-(dimethylamino)octacos-9-enoate Chemical compound CCCCCCCC(N(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OCC AOSJUJLNWRQIPY-QBFSEMIESA-N 0.000 description 1
AHIXVFFUCXQAIK-OWBHPGMISA-N ethyl (z)-21-(dimethylamino)triacont-9-enoate Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OCC AHIXVFFUCXQAIK-OWBHPGMISA-N 0.000 description 1
FUTIFFFCKVWPSF-QBFSEMIESA-N ethyl (z)-21-[(dimethylamino)methyl]heptacos-9-enoate Chemical compound CCCCCCC(CN(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OCC FUTIFFFCKVWPSF-QBFSEMIESA-N 0.000 description 1
NYTVJCNDPOWBQC-OWBHPGMISA-N ethyl (z)-21-[(dimethylamino)methyl]nonacos-9-enoate Chemical compound CCCCCCCCC(CN(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OCC NYTVJCNDPOWBQC-OWBHPGMISA-N 0.000 description 1
GWAHKHXHLSIFNN-QBFSEMIESA-N ethyl (z)-21-[(dimethylamino)methyl]octacos-9-enoate Chemical compound CCCCCCCC(CN(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OCC GWAHKHXHLSIFNN-QBFSEMIESA-N 0.000 description 1
HXYWULKDHNHOSX-OWBHPGMISA-N ethyl (z)-21-[(dimethylamino)methyl]triacont-9-enoate Chemical compound CCCCCCCCCC(CN(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OCC HXYWULKDHNHOSX-OWBHPGMISA-N 0.000 description 1
JGENYNHRIOHZOP-UHFFFAOYSA-N ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCOP([O-])(=O)OCC[N+](C)(C)C JGENYNHRIOHZOP-UHFFFAOYSA-N 0.000 description 1
MPEUOPWWEODARH-UHFFFAOYSA-N ethyl pyrrolidine-3-carboxylate Chemical compound CCOC(=O)C1CCNC1 MPEUOPWWEODARH-UHFFFAOYSA-N 0.000 description 1
230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
206010016256 fatigue Diseases 0.000 description 1
210000004700 fetal blood Anatomy 0.000 description 1
125000001153 fluoro group Chemical group F* 0.000 description 1
229940014144 folate Drugs 0.000 description 1
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
150000004675 formic acid derivatives Chemical class 0.000 description 1
239000013022 formulation composition Substances 0.000 description 1
230000000799 fusogenic effect Effects 0.000 description 1
150000002270 gangliosides Chemical class 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
JFCQEDHGNNZCLN-UHFFFAOYSA-L glutarate(2-) Chemical compound [O-]C(=O)CCCC([O-])=O JFCQEDHGNNZCLN-UHFFFAOYSA-L 0.000 description 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
125000003827 glycol group Chemical group 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
210000004209 hair Anatomy 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
KLHSDMQFUVANEB-MELZOAELSA-L hexadecyl-[(2r,3r)-4-[hexadecyl(dimethyl)azaniumyl]-2,3-dimethoxybutyl]-dimethylazanium;dibromide Chemical compound [Br-].[Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C[C@@H](OC)[C@H](OC)C[N+](C)(C)CCCCCCCCCCCCCCCC KLHSDMQFUVANEB-MELZOAELSA-L 0.000 description 1
235000020256 human milk Nutrition 0.000 description 1
210000004251 human milk Anatomy 0.000 description 1
229940099552 hyaluronan Drugs 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
150000002430 hydrocarbons Chemical group 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000012151 immunohistochemical method Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000015788 innate immune response Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
239000003446 ligand Substances 0.000 description 1
125000002669 linoleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
108010051201 lipid I Proteins 0.000 description 1
238000011068 loading method Methods 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
VLBPIWYTPAXCFJ-XMMPIXPASA-N lysophosphatidylcholine O-16:0/0:0 Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C VLBPIWYTPAXCFJ-XMMPIXPASA-N 0.000 description 1
238000007726 management method Methods 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000013178 mathematical model Methods 0.000 description 1
210000004914 menses Anatomy 0.000 description 1
GWKIZNPISGBQGY-GNLDREGESA-N methyl (2S)-4-[4,6-dimethyl-9-oxo-3-[(2R,3R,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[1,2-a]purin-7-yl]-2-(methoxycarbonylamino)butanoate Chemical class O[C@@]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(=O)N3C(CC[C@@H](C(=O)OC)NC(=O)OC)=C(C)N=C3N(C)C21 GWKIZNPISGBQGY-GNLDREGESA-N 0.000 description 1
YWKJUTVDSHAOGC-VURMDHGXSA-N methyl (z)-16-[2-(dimethylamino)-3-(4-methoxy-4-oxobutoxy)propoxy]hexadec-7-enoate Chemical compound COC(=O)CCCCC\C=C/CCCCCCCCOCC(N(C)C)COCCCC(=O)OC YWKJUTVDSHAOGC-VURMDHGXSA-N 0.000 description 1
AIHAPNLLGYMGNV-VURMDHGXSA-N methyl (z)-16-[2-(dimethylamino)-3-(6-methoxy-6-oxohexoxy)propoxy]hexadec-7-enoate Chemical compound COC(=O)CCCCCOCC(N(C)C)COCCCCCCCC\C=C/CCCCCC(=O)OC AIHAPNLLGYMGNV-VURMDHGXSA-N 0.000 description 1
ZWLDQOBTXOTRBV-VURMDHGXSA-N methyl (z)-16-[2-(dimethylamino)-3-(7-methoxy-7-oxoheptoxy)propoxy]hexadec-7-enoate Chemical compound COC(=O)CCCCCCOCC(N(C)C)COCCCCCCCC\C=C/CCCCCC(=O)OC ZWLDQOBTXOTRBV-VURMDHGXSA-N 0.000 description 1
PBZQJQTVWHAJJT-BENRWUELSA-N methyl (z)-16-[2-(dimethylamino)-3-nonoxypropoxy]hexadec-7-enoate Chemical compound CCCCCCCCCOCC(N(C)C)COCCCCCCCC\C=C/CCCCCC(=O)OC PBZQJQTVWHAJJT-BENRWUELSA-N 0.000 description 1
QXJZGOJJAAYFHV-QBFSEMIESA-N methyl (z)-16-[3-decoxy-2-(dimethylamino)propoxy]hexadec-7-enoate Chemical compound CCCCCCCCCCOCC(N(C)C)COCCCCCCCC\C=C/CCCCCC(=O)OC QXJZGOJJAAYFHV-QBFSEMIESA-N 0.000 description 1
UTEHHFHXPJIZGB-LUAWRHEFSA-N methyl (z)-17-[2-(dimethylamino)-3-octoxypropoxy]heptadec-8-enoate Chemical compound CCCCCCCCOCC(N(C)C)COCCCCCCCC\C=C/CCCCCCC(=O)OC UTEHHFHXPJIZGB-LUAWRHEFSA-N 0.000 description 1
GROYRLVQQIOMDZ-LUAWRHEFSA-N methyl (z)-19-[(dimethylamino)methyl]heptacos-9-enoate Chemical compound CCCCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OC GROYRLVQQIOMDZ-LUAWRHEFSA-N 0.000 description 1
JZGWYYCOAPSLMN-NTMALXAHSA-N methyl (z)-19-[(dimethylamino)methyl]hexacos-9-enoate Chemical compound CCCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OC JZGWYYCOAPSLMN-NTMALXAHSA-N 0.000 description 1
CNLLIGCTRSAIKJ-LUAWRHEFSA-N methyl (z)-19-[(dimethylamino)methyl]octacos-9-enoate Chemical compound CCCCCCCCCC(CN(C)C)CCCCCCCC\C=C/CCCCCCCC(=O)OC CNLLIGCTRSAIKJ-LUAWRHEFSA-N 0.000 description 1
HKAIEGLTCJPXKR-QBFSEMIESA-N methyl (z)-21-(dimethylamino)nonacos-9-enoate Chemical compound CCCCCCCCC(N(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OC HKAIEGLTCJPXKR-QBFSEMIESA-N 0.000 description 1
VUQANPJXAUKFAG-BENRWUELSA-N methyl (z)-21-(dimethylamino)octacos-9-enoate Chemical compound CCCCCCCC(N(C)C)CCCCCCCCCC\C=C/CCCCCCCC(=O)OC VUQANPJXAUKFAG-BENRWUELSA-N 0.000 description 1
XOTXNXXJZCFUOA-UGKPPGOTSA-N methyl 2-[1-[(2r,3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-2,4-dioxopyrimidin-5-yl]acetate Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CC(=O)OC)=C1 XOTXNXXJZCFUOA-UGKPPGOTSA-N 0.000 description 1
WCNMEQDMUYVWMJ-UHFFFAOYSA-N methyl 4-[3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6-dimethyl-9-oxoimidazo[1,2-a]purin-7-yl]-3-hydroperoxy-2-(methoxycarbonylamino)butanoate Chemical compound C1=NC=2C(=O)N3C(CC(C(NC(=O)OC)C(=O)OC)OO)=C(C)N=C3N(C)C=2N1C1OC(CO)C(O)C1O WCNMEQDMUYVWMJ-UHFFFAOYSA-N 0.000 description 1
WZRYXYRWFAPPBJ-PNHWDRBUSA-N methyl uridin-5-yloxyacetate Chemical compound O=C1NC(=O)C(OCC(=O)OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 WZRYXYRWFAPPBJ-PNHWDRBUSA-N 0.000 description 1
230000011987 methylation Effects 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
101150084874 mimG gene Proteins 0.000 description 1
238000009126 molecular therapy Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
VHRYAHCCVUHIBM-NSOMFCEZSA-N n,n-dimethyl-1,2-bis[(6z,9z,12z)-octadeca-6,9,12-trienoxy]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCOC(C)C(N(C)C)OCCCCC\C=C/C\C=C/C\C=C/CCCCC VHRYAHCCVUHIBM-NSOMFCEZSA-N 0.000 description 1
XVUQPECVOGMPRU-ZPPAUJSGSA-N n,n-dimethyl-1,2-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOC(C)C(N(C)C)OCCCCCCCC\C=C/C\C=C/CCCCC XVUQPECVOGMPRU-ZPPAUJSGSA-N 0.000 description 1
FVFQVUFLZVISBL-RAVAVGQKSA-N n,n-dimethyl-1-[(1s,2r)-2-octylcyclopropyl]heptadecan-8-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCC[C@H]1C[C@H]1CCCCCCCC FVFQVUFLZVISBL-RAVAVGQKSA-N 0.000 description 1
UKXOXMLXFQEEQJ-KWXKLSQISA-N n,n-dimethyl-2,3-bis[[(9z,12z)-octadeca-9,12-dienyl]sulfanyl]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCSCC(CN(C)C)SCCCCCCCC\C=C/C\C=C/CCCCC UKXOXMLXFQEEQJ-KWXKLSQISA-N 0.000 description 1
YVWPBXGPSUWRMH-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4,5-bis(dodecylsulfanyl)pentanamide Chemical compound CCCCCCCCCCCCSCC(CCC(=O)NCCN(C)C)SCCCCCCCCCCCC YVWPBXGPSUWRMH-UHFFFAOYSA-N 0.000 description 1
230000008693 nausea Effects 0.000 description 1
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
FJDUDHYHRVPMJZ-UHFFFAOYSA-N nonan-1-amine Chemical compound CCCCCCCCCN FJDUDHYHRVPMJZ-UHFFFAOYSA-N 0.000 description 1
ALXIFCUEJWCQQL-UHFFFAOYSA-N nonan-2-amine Chemical compound CCCCCCCC(C)N ALXIFCUEJWCQQL-UHFFFAOYSA-N 0.000 description 1
230000030147 nuclear export Effects 0.000 description 1
238000001668 nucleic acid synthesis Methods 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
HNRCRTUMPOEQGL-UHFFFAOYSA-N octacos-9-enoic acid Chemical compound CCCCCCCCCCCCCCCCCCC=CCCCCCCCC(O)=O HNRCRTUMPOEQGL-UHFFFAOYSA-N 0.000 description 1
WHOIJCFGVLNXIU-UHFFFAOYSA-N octacosa-19,22-dienoic acid Chemical compound C(CCCCCCCCCCCCCCCCCC=CCC=CCCCCC)(=O)O WHOIJCFGVLNXIU-UHFFFAOYSA-N 0.000 description 1
229940049964 oleate Drugs 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 1
239000011022 opal Substances 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
210000001819 pancreatic juice Anatomy 0.000 description 1
230000007918 pathogenicity Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
PQPFFKCJENSZKL-UHFFFAOYSA-N pentan-3-amine Chemical compound CCC(N)CC PQPFFKCJENSZKL-UHFFFAOYSA-N 0.000 description 1
210000004912 pericardial fluid Anatomy 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
150000008105 phosphatidylcholines Chemical class 0.000 description 1
PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical group NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
150000008299 phosphorodiamidates Chemical class 0.000 description 1
RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 1
125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000000902 placebo Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
210000004910 pleural fluid Anatomy 0.000 description 1
229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
108010011110 polyarginine Proteins 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
229920002714 polyornithine Polymers 0.000 description 1
108010055896 polyornithine Proteins 0.000 description 1
231100000683 possible toxicity Toxicity 0.000 description 1
244000144977 poultry Species 0.000 description 1
235000013594 poultry meat Nutrition 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
229960002429 proline Drugs 0.000 description 1
229940080818 propionamide Drugs 0.000 description 1
SDRUOGAFMUPTQU-UHFFFAOYSA-N propyl 2-(dimethylamino)acetate Chemical compound CCCOC(=O)CN(C)C SDRUOGAFMUPTQU-UHFFFAOYSA-N 0.000 description 1
125000006308 propyl amino group Chemical group 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
210000004908 prostatic fluid Anatomy 0.000 description 1
229940048914 protamine Drugs 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
210000004915 pus Anatomy 0.000 description 1
150000003216 pyrazines Chemical class 0.000 description 1
FICMSTTYJICTDM-UHFFFAOYSA-N pyridazine;triazine Chemical compound C1=CC=NN=C1.C1=CN=NN=C1 FICMSTTYJICTDM-UHFFFAOYSA-N 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
QQXQGKSPIMGUIZ-AEZJAUAXSA-N queuosine Chemical compound C1=2C(=O)NC(N)=NC=2N([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=C1CN[C@H]1C=C[C@H](O)[C@@H]1O QQXQGKSPIMGUIZ-AEZJAUAXSA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000003753 real-time PCR Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
DWRXFEITVBNRMK-JXOAFFINSA-N ribothymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DWRXFEITVBNRMK-JXOAFFINSA-N 0.000 description 1
238000007157 ring contraction reaction Methods 0.000 description 1
238000006049 ring expansion reaction Methods 0.000 description 1
102220089738 rs147911699 Human genes 0.000 description 1
102200088972 rs1801133 Human genes 0.000 description 1
102220053106 rs199537178 Human genes 0.000 description 1
102220031793 rs431825282 Human genes 0.000 description 1
102220045931 rs587782500 Human genes 0.000 description 1
102220088189 rs773831600 Human genes 0.000 description 1
102220059328 rs786202822 Human genes 0.000 description 1
102200024304 rs886037751 Human genes 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
210000002374 sebum Anatomy 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
JRPHGDYSKGJTKZ-UHFFFAOYSA-N selenophosphoric acid Chemical class OP(O)([SeH])=O JRPHGDYSKGJTKZ-UHFFFAOYSA-N 0.000 description 1
238000001338 self-assembly Methods 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
208000013220 shortness of breath Diseases 0.000 description 1
229910000077 silane Inorganic materials 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
229940126586 small molecule drug Drugs 0.000 description 1
239000011734 sodium Substances 0.000 description 1
NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
YNQYZBDRJZVSJE-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl 2,3-di(octadecanoyloxy)propyl phosphate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCCCC YNQYZBDRJZVSJE-UHFFFAOYSA-M 0.000 description 1
210000004988 splenocyte Anatomy 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
108020001568 subdomains Proteins 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
238000012385 systemic delivery Methods 0.000 description 1
210000000538 tail Anatomy 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
239000005450 thionucleoside Substances 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
WCLHZVGJULAEJH-UHFFFAOYSA-N tridecan-2-amine Chemical compound CCCCCCCCCCCC(C)N WCLHZVGJULAEJH-UHFFFAOYSA-N 0.000 description 1
239000013638 trimer Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
230000010415 tropism Effects 0.000 description 1
230000007306 turnover Effects 0.000 description 1
108010087967 type I signal peptidase Proteins 0.000 description 1
238000000870 ultraviolet spectroscopy Methods 0.000 description 1
NHBKWZCTSMCKDS-UHFFFAOYSA-N undecan-2-amine Chemical compound CCCCCCCCCC(C)N NHBKWZCTSMCKDS-UHFFFAOYSA-N 0.000 description 1
RVCNQQGZJWVLIP-VPCXQMTMSA-N uridin-5-yloxyacetic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(OCC(O)=O)=C1 RVCNQQGZJWVLIP-VPCXQMTMSA-N 0.000 description 1
YIZYCHKPHCPKHZ-UHFFFAOYSA-N uridine-5-acetic acid methyl ester Natural products COC(=O)Cc1cn(C2OC(CO)C(O)C2O)c(=O)[nH]c1=O YIZYCHKPHCPKHZ-UHFFFAOYSA-N 0.000 description 1
210000003932 urinary bladder Anatomy 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
239000013598 vector Substances 0.000 description 1
230000007332 vesicle formation Effects 0.000 description 1
230000007502 viral entry Effects 0.000 description 1
230000017613 viral reproduction Effects 0.000 description 1
210000004916 vomit Anatomy 0.000 description 1
QAOHCFGKCWTBGC-QHOAOGIMSA-N wybutosine Chemical compound C1=NC=2C(=O)N3C(CC[C@H](NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QAOHCFGKCWTBGC-QHOAOGIMSA-N 0.000 description 1
QAOHCFGKCWTBGC-UHFFFAOYSA-N wybutosine Natural products C1=NC=2C(=O)N3C(CCC(NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1C1OC(CO)C(O)C1O QAOHCFGKCWTBGC-UHFFFAOYSA-N 0.000 description 1
JCZSFCLRSONYLH-QYVSTXNMSA-N wyosin Chemical compound N=1C(C)=CN(C(C=2N=C3)=O)C=1N(C)C=2N3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JCZSFCLRSONYLH-QYVSTXNMSA-N 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1
RPQZTTQVRYEKCR-WCTZXXKLSA-N zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=CC=C1 RPQZTTQVRYEKCR-WCTZXXKLSA-N 0.000 description 1